Page last updated: 2024-08-21

thiazoles and Benign Neoplasms

thiazoles has been researched along with Benign Neoplasms in 418 studies

Research

Studies (418)

Timeframe	Studies, this research(%)	All Research%
pre-1990	31 (7.42)	18.7374
1990's	22 (5.26)	18.2507
2000's	102 (24.40)	29.6817
2010's	223 (53.35)	24.3611
2020's	40 (9.57)	2.80

Authors

Authors	Studies
Chen, R; Ding, L; Liu, M; Yang, S; Zang, J; Zhao, J; Zhao, X	1
Ahmad, A; Choudhry, H; Dalhat, MH; Khan, MI; Mohammed, MRS	1
Isidori, M; Lavorgna, M; Nugnes, R; Orlo, E; Russo, C	1
Bolek, T; Grilusová, K; Mokáň, M; Samoš, M; Škorňová, I; Staško, J	1
Ahmadvand, H; Hemmati-Dinarvand, M; Seghatoleslam, A	1
Ando, Y; Kiyota, N; Minami, H; Mitsuma, A; Morita, S; Toyoda, M	1
Chen, B; Hu, DX; Liu, JC; Weng, JQ; Yang, JL; Yu, Q	1
Ding, Y; Shi, L; Wang, H; Xu, Z; Yang, Y; Zhang, N; Zhu, M	1
Inoue, S; Maeda, I; Ogawa, A; Terada, S; Yamada, N; Yoshiuchi, K	1
Abbas, AA; Dawood, KM; Mohamed, BE; Nafie, MS; Raslan, MA	1
Kato, S; Odajima, S; Okamoto, A; Saito, M; Seki, T; Shoburu, Y; Suzuki, E; Takano, H; Takenaka, M; Tomita, K; Yamada, K	1
Almilaibary, A	1
Bielawska, A; Bielawski, K; Czarnomysy, R; Finiuk, N; Gzella, A; Holota, S; Ivasechko, I; Kashchak, N; Khyluk, D; Klyuchivska, O; Lesyk, D; Lesyk, R; Roszczenko, P; Senkiv, J; Stoika, R; Yushyn, I	1
Bhat, AA; Singh, I; Tandon, N; Tandon, R	1
Kaur, B; Sharma, V; Singh, G; Singh, I	1
Huang, Z; Li, J; Lou, C; Ye, Y; Zhang, M; Zhang, Y	1
Abdelhai Esawi, O; Abdelhamid, MS; El-Farargy, AF	1
Aljarah, M; Brown, M; Challinor, M; Johnson, L; Lawrence, R; Leung, LMH; Lopes, F; Marais, R; Mcleary, R; Niculescu-Duvaz, D; Pearce, SP; Smithen, DA; Springer, C; Tang, H; Thomson, G	1
Bai, X; Dong, B; Huang, G; Liu, J; Liu, M; Lv, J; Song, H; Sun, J; Sun, L; Sun, X; Xu, L; Xu, W; Zhang, G; Zhang, L	1
Burvenich, IJG; Harris, MA; Hawkins, CJ; Parker, BS; Rigopoulos, A; Scott, AM; Shekhar, TM; Spurling, A; Walkley, CR; Zanker, D	1
Chen, C; Chen, P; Dai, L; Gong, Y; Jia, D; Jin, Z; Liu, D; Lou, J; Niu, D; Qi, X; Shen, X; Sun, Q; Zhang, B; Zhang, X; Zhao, L	1
Bartel, K; Müller, R; von Schwarzenberg, K	1
Gonçalves, MA; Kuca, K; Mancini, DT; Pereira, BTL; Ramalho, TC	1
Antoine, A; Baselga, J; Cantley, LC; Chandarlapaty, S; Chang, MT; Dickler, MN; Friedman, LS; Gorelick, A; Jhaveri, K; Johnson, JL; Kazmi, A; Ladewig, E; Lin, TY; Rabadan, R; Razavi, P; Reznik, E; Scaltriti, M; Schimmoller, F; Sebra, R; Shah, H; Shao, H; Smith, ML; Taylor, BS; Toska, E; Vasan, N; Wilson, TR; Xu, G	1
Pelletier, J; Shen, L	1
Marti, C; Righini, M; Robert-Ebadi, H; Rossel, A; Stebler-Fontaine, L	1
Daveedu, T; Peddanna, K; Sainath, SB; Sekhar, T; Thriveni, P; Venkateswarlu, A	1
Aulicino, J; Gobbooru, S; Kommaraju, SS; Li, J; Low, WK; Romo, D; Zhu, M	1
Amador, LA; Cencic, R; Itoua Maïga, R; Jankowsky, E; Naineni, SK; Pelletier, J; Putnam, AA; Rodriguez, AD	1
Cui, F; Han, Y; Kawashima, Y; Li, S; Liang, N; Liu, J; Sun, S; Yan, P	1
Auditeau, C; Blandinières, A; Gendron, N; Smadja, DM; Talbot, A	1
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z	1
Ageno, W; Casella, IB; Chee, KH; Desch, M; Donado, E; Goldhaber, SZ; Reilly, PA; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I	1
Cao, Y; Liu, H; Ma, N; Wu, Y; Yao, M; Zhang, B	1
Conlon, IL; Drennen, B; Fletcher, S; Hughes, S; Lanning, ME; MacKerell, AD; Rothhaas, R; Wilder, PT	1
Ebner, M; Lankeit, M	1
Lopes, DG; Schipp, B; Siepmann, T; Tamayo, A	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Albertsen, IE; Højen, AA; Larsen, TB; Nielsen, PB; Noble, S; Ording, AG; Overvad, TF; Søgaard, M	1
Gao, H; Long, J; Tang, Z; Wan, Y	1
Appenteng, K; Arana, A; Bahmanyar, S; de Vogel, S; Enger, C; Hallas, J; Hoffman, V; Horter, L; Kristiansen, NS; Linder, M; Margulis, A; Odsbu, I; Olesen, M; Perez-Gutthann, S; Phiri, K; Seeger, J; Suehs, B	1
Helm, J; Kuijlaars, M; McBrearty, A	1
Jerald, MK; Kommalapati, VK; Kumar, D; Tangutur, AD	1
Jain, VK; Kumar, R; Kumar, V; Nagpal, S	1
Liu, Y; Min Chin, J; Phua, KKL; Zhang, W	1
Jung, DW; Kim, HJ; Kim, JH; Kim, SW; Lee, JH; Um, J; Williams, DR	1
Ajipa, O; Andre, F; Beck, JT; Blumenstein, L; Curigliano, G; Donnet, V; Fazio, N; Hubner, RA; Jhaveri, K; Lahner, H; Li, Z; Martin, M; Maur, M; Tortora, G	1
Chen, H; Jin, J; Kaniskan, HÜ; Liu, J; Liu, Y; Meng, F; Shen, Y; Wei, W	1
Ito, M; Nakamura, M; Yamada, N	1
Hong, J; Kim, B; Lee, H; Li, C; Luesch, H; Ratnayake, R; Shi, G; Zeller, SL	1
Langer, F; Voigtlaender, M	1
Davis, DO; Davis, KA	1
Chen, B; Kraus, D; Palasuberniam, P	1
Bayoumi, NA; Darwish, WM; El-Kolaly, MT	1
Jain, S; Kumar, S; Pathak, D; Pathak, K; Pattnaik, S; Vaidya, A	1
Shimada, N; Takasawa, R; Tanuma, SI	1
Büller, HR; Carrier, M; Di Nisio, M; Garcia, D; Grosso, MA; Kakkar, AK; Kovacs, MJ; Mercuri, MF; Meyer, G; Raskob, GE; Segers, A; Shi, M; van Es, N; Verhamme, P; Wang, TF; Weitz, JI; Yeo, E; Zhang, G; Zwicker, JI	1
Bleker, SM; Brekelmans, MPA; Büller, HR; Cohen, AT; Eerenberg, ES; Kraaijpoel, N; Middeldorp, S; Raskob, GE; van Es, N	1
Ginsberg, JS; Hirsh, J	1
Jeong, YY; Lee, BI; Moon, MJ; Park, HJ; Park, IK; Surendran, SP; Thomas, RG	1
Bergholz, JS; Roberts, TM; Zhao, JJ	1
Eguchi, M; Ikeda, S; Kawano, H; Koga, S; Koide, Y; Maemura, K; Muroya, T; Sato, D; Tsuneto, A; Yamagata, Y; Yonekura, T; Yoshimuta, T	1
Connelly, MC; Guy, RK; Hobrath, JV; Mathew, B; Reynolds, RC	1
Bessi, I; Das, T; Dash, J; Debnath, M; Dutta, D; Müller, D; Paul, R; Schwalbe, H	1
Bowler, E; Ladomery, M; Porazinski, S; Uzor, S; Wilson, I; Zorzou, P	1
Barden, S; Campbell, T; Condliffe, R; Connolly, V; Davies, CWH; Donaldson, J; Everett, B; Free, C; Horner, D; Howard, LSGE; Hunter, L; Kaler, J; Nelson-Piercy, C; O-Dowd, E; Patel, R; Preston, W; Sheares, K	1
Abdu-Allah, H; Al-Azawi, AM; El-Awady, R; El-Shorbagi, AN; Menon, V; Ramadan, W; Saleh, E; Tarazi, H; Vazhappilly, CG	1
Afzal, O; Alam, O; Ali, MR; Azim, S; Bawa, S; Chanana, D; Kumar, S; Paudel, YN; Shalmali, N; Sharma, M	1
Büller, HR; Raskob, GE; Segers, A	1
Calabrò, MG; Curigliano, G	1
Hironaka, S	1
Nasser, NJ	1
Dufilho, M; Frere, C	1
Carrier, M; Khorana, AA; Lee, AYY; Meyer, G; Noble, S; O'Connell, C; Soff, G	1
Beyer-Westendorf, J; Büller, HR; Carrier, M; Di Nisio, M; Garcia, D; Grosso, M; Hernandez, CR; Kakkar, AK; Kraaijpoel, N; Mercuri, MF; Middeldorp, S; Mulder, FI; Raskob, GE; Santamaria, A; Schwocho, L; Segers, A; van Es, N; Verhamme, P; Wang, TF; Weitz, JI; Zhang, G; Zwicker, JI	1
Alam, MA; Ali, MA; Alsharif, ZA; Chambers, SA; Okolo, C; Varma, RS; Whitt, J	1
Bischoff, I; Bräutigam, J; Fürst, R; Luong, B; Menche, D; Müller, R; Schwenk, R	1
Di Nisio, M	1
Maurea, N; Riva, L	1
Eguchi, M; Ikeda, S; Kawano, H; Koga, S; Koide, Y; Maemura, K; Sato, D; Tsuneto, A; Yamagata, Y; Yonekura, T; Yoshimuta, T	1
Chen, LZ; Kong, FL; Lu, YD; Shen, FQ; Wang, MH; Wang, ZC; Yang, MR; You, LX; Zhu, HL	1
Antman, EM; Babilonia, NA; Braunwald, E; Duggal, A; Fanola, CL; Giugliano, RP; Jin, J; Kamphuisen, PW; Mercuri, MF; Murphy, SA; Ruff, CT; Sritara, P	1
Själander, A; Själander, S	1
Anders, HJ; Fujikura, T; Iwakura, T; Tsuji, T; Yasuda, H	1
Ando, Y; Iwasa, S; Kakizume, T; Natsume, K; Quadt, C; Saka, H; Suenaga, N; Takahashi, S; Yamada, Y	1
An, T; Deng, X; Hu, C; Jin, Z; Ma, Q; Meng, Q; Tan, X; Wang, C	1
Ebato, M; Higashino, M; Hozumi, T; Kogo, M; Matsui, M; Nakamura, S; Sasaki, T; Shimizu, T; Sunaga, T; Suzuki, H; Takahashi, N; Watanabe, T	1
Becattini, C; Giustozzi, M; Vedovati, MC	1
de Lima Ferreira, LP; de Melo Rêgo, MJB; de Moraes Gomes, PAT; de Siqueira, LRP; Leite, ACL	1
Oo, TH; Rojas-Hernandez, CM	1
Carrier, M; Kimpton, M	1
Cen, X; Jie, H; Li, Y; Li, Z; Lin, Y; Liu, C; Qian, X; Tao, L; Yang, S; Zhang, H; Zhao, Y; Zhou, Y; Zuo, Z	1
Arnesano, F; Cheng, L; Li, C; Liu, Y; Natile, G; Shi, H; Yuan, S; Zhang, L; Zhao, L	1
Borisova, B; Ceruso, M; Cornelio, B; De Grandis, M; Dontchev, D; Fontana, A; Laronze-Cochard, M; Machado, C; Miambo, R; Riccioni, R; Sapi, J; Supuran, CT	1
Garcia, DA; Li, A; Lyman, GH; Manohar, PM; Steuten, LM	1
Connell, NT; Connors, JM	1
Buller, H; Carrier, M; Di Nisio, M; Garcia, D; Raskob, G; Segers, A; van Es, N; Wang, TF; Weitz, J	1
Ashour, HMA; El-Wakil, MH; El-Yazbi, AF; Ismail, KA; Khalil, MA; Labouta, IM	1
Chen, H; Deng, Y; Li, S; Tong, Y; Zou, L	1
Ayati, A; Emami, S; Foroumadi, A; Moghimi, S	1
Hasegawa, K; Miyazaki, Y; Morimoto, T; Sase, K	1
Blair, LP; Cao, J; Hoyer, D; Merkel, JS; Morales, A; Norcia, M; Sayegh, J; Tackett, AJ; Yan, Q; Zou, MR	1
Bu, W; Chen, F; Fan, W; He, Q; Liu, J; Ni, D; Peng, W; Shen, B; Shi, J; Xiao, Q; Xing, H; Zhang, S; Zhao, K; Zhou, L	1
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kikuchi, J; Nobuyoshi, M; Ohki, M; Park, SY; Shibayama, N; Sugiyama, K; Wada, T; Yamada, S	1
Behrsing, H; Kaur, G; Millin, MD; Parchment, RE; Teicher, BA	1
Bi, M; Cai, Q; Meng, W; Ni, Y; Wang, B; Wang, J	1
Ashworth, A; Campbell, J; Herrera-Abreu, MT; Knowles, MA; Pearson, A; Shnyder, SD; Turner, NC	1
Cao, JT; Min, QH; Zhang, PH; Zhu, JJ	1
Ju, E; Li, Z; Liu, Z; Qu, X; Ren, J; Zhou, L	1
Kono, B; Kurosawa, H; Takei, D; Yomiya, K	1
Bowers, AA; Bradner, JE; Estiu, G; Guerra-Bubb, JM; Paranal, R; Smith, WB; Wiest, O; Williams, RM	1
Ashraf, MI; Cutress, RI; Deutsch, M; Enthammer, M; Khalid, S; Koziel, K; Packham, G; Papadakis, ES; Salomé Gachet, M; Schwaiger, S; Stuppner, H; Troppmair, J; Wolber, G	1
Gaur, S; Horne, D; Hu, S; Hu, W; Smith, DL; Su, L; Synold, TW; Wu, J; Yen, Y; Yip, ML; Yuan, YC; Zhou, B	1
He, HW; Shao, RG; Zhang, CX	1
Arnold, GJ; Fröhlich, T; Kubisch, R; Roidl, A; Schreiner, L; Vollmar, AM; von Schwarzenberg, K; Wagner, E	1
Lione, L; Mackenzie, LS	1
Chiang, HH; Kohane, DS; Tong, R	1
Bantu, R; Kumar, CG; Nagarapu, L; Nanubolu, J; Pombala, S; Yadagiri, B	1
Chen, M; Chen, X; Nie, L; Rong, P; Sun, X; Zheng, N	1
Christensen, J; Shastri, VP; Voigt, J	1
Ali, AR; El-Bendary, ER; Ghaly, MA; Shehata, IA	1
Boehm, M; Brachmann, SM; Caravatti, G; Chatenay-Rivauday, C; Chene, P; Cozens, R; De Pover, A; Erdmann, D; Ferretti, S; Fritsch, C; Furet, P; Gao, H; Garcia-Echeverria, C; Guthy, D; Hofmann, F; Huang, A; Kauffmann, A; Lehar, J; Liu, M; Maira, SM; Reddy, A; Schlegel, R; Schnell, C; Sellers, WR; Trappe, J; Wang, Y; Wiesmann, M; Wilson, C	1
Boehm, M; Bootle, D; De Buck, SS; Goggin, TK; Jakab, A; Juric, D; Quadt, C	1
Chang, CW; Chen, FD; Chen, YC; Hsieh, YJ; Hwu, L; Ke, CC; Lin, KP; Liu, RS; Wang, HE; Yeh, HH	1
Chamberlin, AR; Chen, W; Chien, R; Guo, XE; Hu, CM; Kim, Y; Lee, EY; Lee, WH; Lopez, R; Ngo, B; Qiu, XL; Tsai, CY; Wang, YV; Wu, G; Zhu, J	1
Luo, ZL; Qiu, HY; Wang, PF; Wang, SF; Yang, YA; Yin, Y; Yuan, JW; Zhang, F; Zhang, X; Zhu, HL	1
Abd-Allah, GM; Ghobara, M; Hassan, MH	1
Brazzelli, V; Croci, G; Grasso, V; Vassallo, C	1
Beer, JH; Holy, EW	1
Balasubramanian, PK; Balupuri, A; Cho, SJ; Gadhe, CG	1
Andersen, MH; Berthelsen, J; Bonefeld, CM; Francavilla, C; Fredholm, S; Geisler, C; Hu, T; Krejsgaard, T; Odum, N; Olsen, JV; Petersen, DL; Sibbesen, NA; Wasik, MA; Willerslev-Olsen, A; Woetmann, A; Zhang, M	1
Chen, K; Johnston, N; Liu, Q; Ma, Z; Wang, W; Zhang, F; Zheng, X	1
Cameron, S; Cohen, RB; Dees, EC; Dhuria, SV; Infante, JR; Olszanski, AJ; Sen, S	1
Fulda, S	1
London, CA	1
Bister, K; Hart, JR; Hartl, M; Janda, KD; Raffeiner, P; Röck, R; Schraffl, A; Stefan, E; Vogt, PK	1
Chekkara, R; Gorla, VR; Susithra, E; Tenkayala, SR	1
Avula, S; Chilaka, DR; Komsani, JR; Koppireddi, S; Kotamraju, S; Yadla, R	1
Abdelazeem, AH; Gouda, AM; Omar, HA; Tolba, MF	1
Bil, J; Bobrowicz, M; Bojarczuk, K; Dabrowska-Iwanicka, A; Dwojak, M; Efremov, DG; Golab, J; Juszczynski, P; Krol, M; Le Roy, A; Leusen, JH; Miazek, N; Olive, D; Pilch, Z; Podszywalow-Bartnicka, P; Pyrzynska, B; Rygiel, TP; Siernicka, M; Slabicki, M; Syta, A; Winiarska, M; Zagozdzon, A; Zapala, P; Zenz, T	1
Chen, HZ; Dong, X; Fang, C; Gao, YG; Guan, YY; Liu, HJ; Liu, YR; Lu, Q; Luan, X; Wang, C; Yang, SC	1
Barry, ST; Baselga, J; Carver, BS; Chandarlapaty, S; de Stanchina, E; Hancox, U; Rodrik-Outmezguine, V; Rosen, N; Sawyers, CL; Scher, HI; Schwartz, S; Trigwell, CB; Will, M; Wongvipat, J; Yellen, P	1
Deng, S; Gong, C; Liu, L; Liu, S; Song, L; Su, W; Wang, N; Wei, Y; Wu, Q; Xie, Y; Zhang, N	1
Cescon, DW; Gorrini, C; Mak, TW	1
Brimble, MA; Harris, PW	1
Jean-Claude, BJ; Larroque-Lombard, AL; Peyrard, L; Rachid, Z; Rao, S; Thauvin, C; Williams, C	1
Bonfanti, C; Franchini, M; Lippi, G	1
Agnelli, G; Prandoni, P; Verso, M	1
Di Santo, N; Ehrisman, J	1
Attanzio, A; Barraja, P; Carbone, A; Ciancimino, C; Cirrincione, G; Di Vita, G; Diana, P; Livrea, MA; Montalbano, A; Parrino, B; Spanò, V; Tesoriere, L	1
MegallyAbdo, NY; Mohareb, RM	1
Leoni, A; Locatelli, A; Morigi, R; Rambaldi, M	1
Fairhurst, RA; Fritsch, C; Furet, P; Gerspacher, M; Guthy, DA; Mah, R; Roehn-Carnemolla, E	1
Arz, D; Blanz, J; Blasco, F; Caravatti, G; Desrayaud, S; Fairhurst, RA; Fritsch, C; Furet, P; Gerspacher, M; Guthy, DA; Imbach-Weese, P; Knapp, M; Luu, VH; Mah, R; Roehn-Carnemolla, E; Schnell, C; Wirth, J	1
Beyer-Westendorf, J; Bleker, SM; Boda, Z; Büller, HR; Carrier, M; Chlumsky, J; Décousus, H; Di Nisio, M; Garcia, D; Gibbs, H; Grosso, MA; Kakkar, A; Kamphuisen, PW; Mercuri, MF; Monreal, M; Ockelford, P; Pabinger, I; Raskob, GE; Schwocho, L; Segers, A; van Es, N; Verhamme, P; Weitz, JI	1
Ishioka, C; Yoshino, Y	1
Abe, K; Akagi, T; Matoba, M; Mawatari, H; Saito, O; Syuuto, C; Tagami, K; Takeno, N	1
Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Cheminel, T; Grozav, A; Therrien, B	1
Albericio, F; Cosialls, AM; Gil, J; González-Gironès, DM; Iglesias-Serret, D; Korwitz, A; Langer, T; Lavilla, R; Moncunill-Massaguer, C; Núñez-Vázquez, S; Palmeri, CM; Pérez-Perarnau, A; Pomares, H; Pons, G; Preciado, S; Saura-Esteller, J	1
Arteaga, CL; Bose, R; Button, B; Chu, D; Cidado, J; Cimino-Mathews, A; Cochran, RL; Cravero, K; Croessmann, S; Dalton, WB; Erlanger, B; Kavuri, SM; Konstantopoulos, K; Kyker-Snowman, K; Lauring, J; Manto, KM; Park, BH; Parsons, HA; Red Brewer, M; Rosen, DM; Wong, HY; Yankaskas, CL; Zabransky, DJ	1
Quesne, JL; Raza, F; Waldron, JA	1
Amin, M; Hille, D; Krishnamurthi, SS; Lockhart, AC; LoRusso, PM; Lunceford, J; Mauro, D; Minton, SE; Pickett, CA; Stein, MN; Trull, L; Wang-Gillam, A	1
Giordano, A; Morales, F	1
Cai, Y; Lu, C; Makala, L; Wu, D	1
Chen, F; Gao, AH; Gong, CJ; Li, J; Li, JY; Nan, FJ; Sheng, L; Su, MB; Zhang, YM; Zhou, YB	1
Abdel-Moty, SG; Abdu-Allah, HH; El-Awady, R; El-Shorbagi, AN	1
Fujimaki, K; Fujisaki, T; Gemba, K; Goto, T; Kaneko, M; Kawai, Y; Kiguchi, T; Kirito, K; Maemondo, M; Nakajima, A; Okamoto, M; Takeda, K; Tamura, K; Ueda, T	1
Dimri, GP; Dimri, M; Kang, M	1
Lehr, T; Menche, D; Müller, R; Schneider, LS; Ulrich, M; von Schwarzenberg, K	1
Kłoczko, J; Ołdziej, AE; Romaniuk, W; Zińczuk, J	1
Bensinger, SJ; Cheung, K; Gholkar, AA; Hamideh, SA; Khuu, C; Lo, YC; Nnebe, C; Torres, JZ; Williams, KJ	1
Noble, SI	1
Angchaisuksiri, P; Boda, Z; Büller, HR; Gudz, I; Lanz, H; Lyons, RM; Meijer, K; Mercuri, MF; Oh, D; Raskob, GE; Segers, A; van Es, N; Weitz, JI; Zhang, G	1
Davies, AH; Lim, CS; Ravikumar, R	1
Chen, Y; Dong, Y; Jiang, Z; Li, Y; Pei, H; Peng, Y; Shao, T; Sun, Z; Tang, W; Wang, J; Yi, Z; Zhou, W	1
Hayashi, K; Iwasaki, M; Matsumoto, K; Minato, N; Morita, CT; Murata-Hirai, K; Okamura, H; Tanaka, Y	1
Miura, K; Philchenkov, A	1
Asma Naqvi, S; Choudhary, MI; Mirza, S; Mohammed Khan, K; Salar, U	1
Beijnen, JH; Fox, JA; Huitema, ADR; Jamieson, GC; Lucas, L; Mergui-Roelvink, M; Mould, DR; Nijenhuis, CM; Rosing, H; Schellens, JHM	1
Bhargava, P; Kaul, SC; Lee, JS; Na, Y; Ryu, J; Wadhwa, R; Yun, CO	1
Alqahtani, S; Ambudkar, SV; Anreddy, N; Chen, ZS; Kaddoumi, A; Patel, BA; Shukla, S; Singh, S; Talele, TT; Wang, YJ; Zhang, GN; Zhang, YK	1
Fekrazad, HM; Mills, DA; Verschraegen, CF	1
Tuma, RS	1
Böttger, SA; Walker, CW	1
Aquila, BM; Bebernitz, GA; Cook, DJ; Dakin, LA; Deegan, TL; Hattersley, MM; Ioannidis, S; Lyne, PD; Omer, CA; Scott, DA; Ye, M; Zheng, X	1
Chan, DA; Giaccia, AJ	1
Furutani, Y; Hoch, U; Kajikawa, F; Kashimoto, S; Lynch, J; Sato, Y; Silverman, JA	1
Gzella, A; Havrylyuk, D; Lesyk, R; Vasylenko, O; Zaprutko, L; Zimenkovsky, B	1
Chen, M; Chen, Z; Liu, G; Peng, Y; Wu, M; Xu, B	1
Fu, JJ; Hu, XJ; Jin, HZ; Qin, JJ; Wang, Y; Yan, SK; Zhang, WD	1
Gong, C; Guo, C; Lin, W; Liu, C; Liu, W	1
Chen, L; Huang, X; Liu, P	1
Anitha, P; Feng, SS; Gan, CW; Mei, L; Zhou, W	1
Huan, ML; Liu, XY; Mei, QB; Teng, ZH; Wang, JP; Zhang, BL; Zhou, SY	1
Berger, W; Dornetshuber, R; Heffeter, P; Hoda, MA; Jungwirth, U; Kiss, R; Mijatovic, T	1
Agoulnik, S; Boivin, R; Chen, Z; Du, H; Jiang, Y; Kuznetsov, G; Littlefield, BA; Liu, J; Marsh, J; Parent, L; Romo, D; Rudolph-Owen, L; Shie, JL; Tendyke, K; Towle, M; Twine, N; Wang, Y; Xu, Q; Zhang, H; Zhao, N	1
Chan, HY; Chen, MH; Jeng, JH; Shen, KT; Wang, YJ	1
Decosterd, LA; Duchosal, MA; Haouala, A; Leyvraz, S; Montemurro, M; Ris, HB; Rochat, B; Widmer, N; Zaman, K; Zanolari, B	1
Anguiano, J; Das, BC; Madhukumar, AV; Mani, S	1
Bianco, S; Lanvin, O; Macari, C; North, S; Tribollet, V; Vanacker, JM	1
Arbitrario, JP; Belmont, BJ; Evanchik, MJ; Flanagan, WM; Fucini, RV; Hansen, SK; Harris, SO; Hashash, A; Hoch, U; Hogan, JN; Howlett, AR; Jacobs, JW; Lam, JW; Ritchie, SC; Romanowski, MJ; Silverman, JA; Stockett, DE; Taverna, P; Teague, JN; Zimmerman, KM	1
Apáti, A; Hegedus, C; Katona, M; Kéri, G; Magócsi, M; Német, K; Orfi, L; Ozvegy-Laczka, C; Sarkadi, B; Szakács, G; Takáts, Z; Váradi, A	1
Agrawal, S; Brunton, VG; Demetri, GD; Evans, TR; Lo Russo, P; MacPherson, IR; Morgan, JA; Paliwal, P; Voi, M; Wang, D	1
Ashby, CR; Chen, A; Chen, X; Chen, ZS; Hopper-Borge, E; Kuang, YH; Lei, Y; Ouyang, J; Shen, T; Tiwari, AK; Zhou, Y	1
Becuwe, P; Bouli, S; Gargouri, M; Maincent, P; Merlin, JL; Sapin, A	1
Klein, RQ; Lok, W; Saif, MW	1
Karminski-Zamola, G; Kralj, M; Racané, L; Stojković, R; Suman, L; Tralić-Kulenović, V	1
Gartel, AL	1
Chung, AS; Ferrara, N	1
Agrawal, S; Blackwood-Chirchir, A; Burris, H; Chiappori, AA; Dhillon, N; Hong, D; Johnson, FM; Kaul, S; Luo, FR; Rosen, L; Sy, O	1
Haura, EB; Kim, LC; Rix, U	1
Hada, T; Kumamoto-Yonezawa, Y; Matsui, Y; Mizushina, Y; Sasaki, R; Sugimura, K; Suzuki, Y; Uryu, K; Yoshida, H	1
Bourbeau, MP; Dominguez, C; Freeman, D; Hoffman, D; Huang, X; Hungate, R; Lee, MR; Li, C; Lofgren, J; Monenschein, H; Rider, JT; Tasker, AS; Tominey, E; Viswanadhan, VN; Wohlhieter, GE; Yamane, H; Yao, G; Zeng, Q; Zhang, S; Zhang, X	1
Adler, V; Bowne, WB; Michl, J; Pincus, MR; Sarafraz-Yazdi, E; Sookraj, KA	1
Araujo, J; Logothetis, C	1
Adelman, DC; Advani, RH; Allen, RS; Berman, CJ; Ebbinghaus, SW; Fox, JA; Gordon, MS; Havrilla, NA; Hoch, U; Hurwitz, HI; Mendelson, DS; Silverman, JA; Wakelee, HA	1
Badria, FA; Dawood, KM; Hegazi, B; Mohamed, HA	1
Casolaro, M; Chiasserini, L; Cini, R; Gabbiani, C; Hursthouse, MB; Jakupec, MA; Keppler, BK; Magnani, A; Messori, L; Sega, A; Tamasi, G; Valiahdi, SM	1
Miller, JH; Northcote, PT; Singh, AJ	1
Chen, LM; Fu, LW; Liang, YJ; Lin, YC; Mi, YJ; She, ZG; Tao, LY; To, KK; Wang, F; Zhang, JY; Zhen, LS	1
Botta, M; Brullo, C; Musumeci, F; Schenone, S	1
Krämer, A; Kreis, NN; Rödel, F; Sanhaji, M; Sommer, K; Strebhardt, K; Yuan, J	1
Vollmar, AM; von Schwarzenberg, K	1
Agostino, NM; Chinchilli, VM; Drabick, JJ; Gingrich, R; Koszyk-Szewczyk, A; Lynch, CJ; Sivik, J	1
Almeida, J; Bandarra, D; Brandão, P; Calhorda, MJ; Félix, V; Lopes, M; Lopes, T; Meireles, M; Nunes, CD; Saraiva, MS; Vasconcellos-Dias, M; Vaz, PD	1
Beumer, JH; Clausen, DM; Egorin, MJ; Eiseman, JL; Guo, J; Lazo, JS; Parise, RA; Prochownik, EV	1
Chang, CY; Dwyer, MA; Eaton, ML; Joseph, JD; Kazmin, D; Kunder, RS; McDonnell, DP; Wade, HE	1
Dempke, W; Zippel, R	1
Cai, LP; Dong, M; Liu, WP; Mo, YQ; Tu, CH; Yang, DZ	1
Gnoni, A; Lorusso, V; Marech, I; Silvestris, N; Vacca, A	1
Adamson, PC; Agrawal, S; Aplenc, R; Balis, FM; Blaney, SM; Ingle, AM; Shusterman, S; Strauss, LC; Sun, J; Wright, JJ	1
Chakravarty, AR; Khan, I; Koley, D; Kondaiah, P; Prasad, P; Sasmal, PK	1
Gartel, AL; Pandit, B	1
Lindqvist, L; Pelletier, J	1
Angiolini, M	1
Li, L; Li, X; Liu, A; Liu, Y; Yan, B; Zhang, Q; Zhou, H	1
Chang, D; Hammond, PT; Poon, Z; Zhao, X	1
Eadens, M; Messersmith, W; Puls, LN	1
Barraja, P; Carbone, A; Cirrincione, G; Diana, P; Lopergolo, A; Montalbano, A; Parrino, B; Pennati, M; Zaffaroni, N	1
Jin, X; Kong, D; Li, C; Wang, T; Wu, D; Wu, Y; Yu, Z; Zhang, C; Zhang, L; Zhao, R	1
Geoerger, B; Leblond, P	1
Boos, J; Lanvers-Kaminsky, C; Spaniol, K	1
Montero, JC; Ocaña, A; Pandiella, A; Seoane, S	1
Liu, R; Liu, W; Song, N; Tu, Q; Wang, J; Zhang, Y	1
Chircop, M; Gilbert, J; Gordon, CP; Jones, NC; Lau, H; Ma, MP; Mariana, A; McCluskey, A; Morokoff, A; O'Brien, TJ; Perera, S; Robinson, PJ; Sakoff, J; Young, KA	1
Bongarzone, I; Caccia, D; Carniti, C; De Bortoli, M; Miccichè, F; Mondellini, P; Zanetti Domingues, L	1
Hatake, K; Ito, Y; Miyazaki, M; Nakagawa, K; Okamoto, I; Seriu, T; Takahashi, S; Ueda, K	1
Akahane, K; Haginoya, N; Horiuchi, T; Kitagawa, M; Miyazaki, M; Nagata, M; Takeda, Y; Uoto, K	1
Agrawal, S; Appleman, LJ; Argiris, A; Egloff, AM; Feinstein, TM; Grandis, JR; Stoller, RG; Wang, L; Yang, T	1
Chen, L; Chen, Y; Fang, X; Gao, X; Gu, J; Jiang, X; Jiang, Y; Law, K; Ren, Q; Ren, X; Sha, X; Wang, X; Xin, H	1
Ashcraft, B; Doucette, R; Havko, N; Melly, GC; O'Neil, GW; Sebren, LJ; Tran, AB; Young, JC	1
Garcia, C; Gratacap, MP; Lhermusier, T; Payrastre, B; Van Rothem, J	1
Balzarini, J; Baraldi, PG; Basso, G; Bortolozzi, R; Brancale, A; Fu, XH; Hamel, E; Kimatrai Salvador, M; Li, J; Lopez Cara, C; Romagnoli, R; Viola, G; Zhang, SZ	1
El-Gamal, MI; Lee, YS; Oh, CH; Park, JH	1
Buschini, A; Ferrarini, L; Galati, S; Mazzeo, T; Miglio, C; Milano, F; Pellegrini, N; Rossi, C	1
Choi, H; Fiorilla, C; Gerwick, WH; Malloy, KL; Matainaho, T; Valeriote, FA	1
Nagi Reddy, M; Rajanarendar, E; Rama Murthy, K; Reddy, RN; Reddy, YN; Surendar, P	1
Basile, MA; Bencivenga, D; Borriello, A; Caldarelli, I; Della Ragione, F; Oliva, A; Perrotta, S; Tramontano, A	1
Gang, SS; Hariharapura, RC; Jagani, HV; Josyula, VR; Palanimuthu, VR	1
Jeong, SC; Jeong, YT; Koyyalamudi, SR; Pang, G; Song, CH	1
Herbolsheimer, P; Jelinek, J; Kapoor, R; Perry, D; Smith, KL; Swain, SM; Verma, N; Veytsman, I	1
Cui, M; Gao, J; Gu, G; Li, X; Liu, S; Lou, HX	1
Choi, KS; Choi, SY; Kim, YS; Seo, YJ; Yang, J	1
DeSimone, JM; Finniss, M; Gullapalli, A; Luft, JC; Napier, ME; Pandya, A; Parrott, MC	1
Cheng, Y; Gust, R; Liu, W; Qi, F; Qian, H; Wang, J; Zhang, H; Zheng, Y; Zhou, J	1
Blair, LJ; Cheng, JQ; Dickey, CA; Gestwicki, JE; Guo, J; Jinwal, UK; Kiray, J; Koren, J; Li, X; Miyata, Y; Nguyen, L; O'Leary, JC	1
Appold, L; Fokong, S; Jorge, S; Kiessling, F; Koczera, P; Lammers, T; Resch-Genger, U; Storm, G; Theek, B; van Zandvoort, M; Wu, Z	1
Ano Bom, AP; Braga, CA; Cepeda, AO; Cordeiro, Y; Costa, DC; De Moura Gallo, CV; de Oliveira, GA; Gava, LM; Ramos, CH; Rangel, LP; Sanches, D; Silva, JL; Stumbo, AC	1
Al Numair, KS; Alsaif, MA; Baskar, AA; Ignacimuthu, S	1
Gu, L; Jin, C	1
Airley, R	1
Dadmal, TL; Janaki Ramaiah, M; Kosurkar, UB; Kumbhare, RM; Pal-Bhadra, M; Pushpavalli, SN	1
Boeckler, FM; Fersht, AR; Wang, G; Wilcken, R	1
Argyle, DJ; Bavcar, S	1
Ding, YH; Gong, J; Lan, R; Lin, G; Lu, F; Wang, J; Wang, Y; Xu, J; Yang, Z; Yin, F; Zhang, H; Zhang, X	1
Dong, X; Guan, X; Hu, Y; Huang, W; Liu, X; Su, Y; Wu, P; Zhang, J	1
Balakrishnar, B; Clements, A; Gao, B; Gurney, H; Wong, M; Yeap, S	1
Al-Omary, FA; El-Messery, SM; El-Subbagh, HI; Hassan, GS	1
Aonuma, M; Fukutake, S; Ikeda, M; Kawato, H; Kitagawa, M; Miyazaki, M; Naito, H; Seki, T; Soga, T	1
Carotti, A; Catto, M; Indiveri, C; Introcaso, A; Koutentis, PA; Koyioni, M; Michaelidou, SS; Nicolotti, O; Oppedisano, F; Pochini, L	1
Covell, DG	1
Gadher, SJ; Hajduch, M; Halada, P; Hrabakova, R; Kollareddy, M; Kovarova, H; Tyleckova, J	1
Gates, KS; Keerthi, K; Rajapakse, A; Sun, D	1
Choe, JH; Choe, JM; Falchook, GS; Gallick, GE; George, GC; Hong, DS; Kurzrock, R; Moulder, SL; Naing, A; Piha-Paul, S; Strauss, LC; Wheler, JJ	1
Liu, S; Ouchi, T; Saeki, T; Shionome, Y; Yan, L	1
Colgin, L; Kaul, SC; Reddel, RR; Taira, K; Wadhwa, R; Yaguchi, T	1
Joo, SS; Kim, HJ; Kwon, HS; Lee, DI	1
Eeckman, F; Johnson, PH; Jones, SW; Luke, MM; McCarrick, MA; Meurer, J; Monforte, J; Morgan, TK; Parry, G; Stephens, K; Tan, Y; Walker, RP; Wong, L; Zajchowski, DA	1
Devière, J	1
LaMont, JT; Li, CJ; Li, Y; Pardee, AB; Sun, X	1
DiGiammarino, EL; Galea, C; Jun, B; Kriwacki, RW; Lee, AS; Murti, G; Ribeiro, RC; Schultz, CP; Zambetti, G	1
Auwerx, J; Egler, V; Fajas, L; Lefebvre, AM; Miard, S; Reiter, R	1
Bollag, WB; Dickinson, D; Hsu, S; Lewis, J; Lockwood, P; Osaki, T; Schuster, G; Singh, B; Ueta, E; Wataha, J; Yamamoto, T	1
Chen, SS; Heber, D; Ikezoe, T; Koeffler, HP; Taguchi, H; Tong, XJ	1
MCKEOGH, J; SHAW, FH	1
KOSANOVIC, B	1
ECKENHOFF, JE; NORTON, ML	1
CRANSTON, EM	1
FEDOSEEV, VM; SILAEV, AB; ZUBOVA, OV	1
INOUE, S; NAGANO, H; NODIFF, EA; SAGGIOMO, AJ	1
IGARASHI, Y; IKEDA, M; MIURA, K; OKADA, I; OOHASHI, T	1
FALKSON, G; FALKSON, HC	1
Covell, DG; Monks, A; Rabow, AA; Shoemaker, RH; Thanki, N; Wallqvist, A	1
Kaipainen, A; Kieran, MW; Panigrahy, D; Shen, LQ	1
Akaike, T; Fang, J; Greish, K; Maeda, H; Sawa, T	1
SPAMPINATO, V	1
Ahn, SM; Jeong, SJ; Kim, YS; Moon, A; Sohn, Y	1
Alaoui-Jamali, MA; Chow, TY; Griller, D; Yeh, C; Yuen, L	1
Alley, MC; Bradshaw, TD; Brantley, E; Hose, CD; Sausville, EA; Stevens, MF; Stinson, SF; Trapani, V	1
Jiang, B; Liu, W; Meng, L; Ouyang, T; Qu, H; Shou, C; Song, S	1
Alberti, P; Canevari, S; Figini, M; Mezzanzanica, D; Turatti, F; Willemsen, RA	1
Gopalakrishna, P; Kaur, T; Manogaran, PS; Pande, G	1
Broekhuizen, AJ; Creutzig, U; Gibson, B; Hubeek, I; Kaspers, GJ; Peters, GJ; Schouten van Meeteren, AY; Talianidis, I; van Wering, ER	1
Antony, S; Das, S; Nama, S; Somasundaram, K	1
Chang, JH; Chang, YL; Cheng, FC; Guh, JH; Kuo, SC; Lee, FY; Pan, SL; Peng, CY; Teng, CM; Wang, SW	1
Blagden, S; de Bono, J	1
Abderrahmani, A; Haefliger, JA; Leisinger, HJ; Martin, D; Tawadros, T; Waeber, G	1
Achilefu, S; Bloch, S; Chance, B; Dorshow, RB; Liang, K; Markiewicz, MA; Ye, Y; Zhong, T	1
He, L; Ji, BS; Liu, GQ	1
Casati, B; Diodovich, C; Ferrario, D; Gribaldo, L; Malerba, I; Marafante, E; Parent-Massin, D	1
Hu, X; Lu, Q; Qiangrong, P; Wang, T	1
Estes, N; Gondi, CS; Gujrati, M; Jutla, A; Lakka, SS; Pulukuri, SM; Rao, JS	1
Dong, Y; Hatano, N; Izumori, K; Sui, L; Tokuda, M; Tsukamoto, I; Watanabe, Y; Yamaguchi, F	1
Bosnjak, B; Dikic, I; Gall-Troselj, K; Katic, M; Pavelic, K	1
Giri, S; Rattan, R; Singh, AK; Singh, I	1
Batist, G; Haïdara, K; Shi, QW; Zamir, L	1
Brouwer, J; den Dulk, H; Pantoja, E; Reedijk, J; Soriano, R; Soro, C; Spek, AL; Tooke, DM; van Zutphen, S	1
Boutros, R; Dozier, C; Ducommun, B	1
Amino, N; Hisamichi, H; Ideyama, Y; Kudoh, M; Kuromitsu, S; Matsuhisa, A; Samizu, K; Shibasaki, M; Shirasuna, K; Tajinda, K; Yamano, M	1
Böttger, S; Low, B; Walker, C	1
Million, RP	1
Ballard, P; Bradbury, RH; Harris, CS; Hennequin, LF; Hickinson, M; Kendrew, J; Kettle, JG; Klinowska, T; Ogilvie, DJ; Pearson, SE; Williams, EJ; Wilson, I	1
Khandare, JJ; Minko, T; Pakunlu, RI; Saad, M; Starovoytov, V; Wang, Y	1
Curtiss, FR	1
Ahmed, S; Andreoni, F; Boschelli, F; Cleris, L; Coluccia, AM; Donella-Deana, A; Formelli, F; Gambacorti-Passerini, C; Magistroni, V; Marchesi, E; Piazza, R; Puttini, M; Redaelli, S; Scapozza, L	1
Andreani, A; Burnelli, S; Farruggia, G; Granaiola, M; Kunkel, MW; Leoni, A; Locatelli, A; Masotti, L; Morigi, R; Rambaldi, M; Stefanelli, C; Varoli, L	1
Chan, AS; Cheng, CH; Cheng, GY; Cheung, F; Chui, CH; Gambari, R; Kok, SH; Lai, PB; Lam, WS; Lau, FY; Tang, JC; Teo, IT; Wong, RS; Yu, MW	1
Du, G; Hang, H; Liang, W; Liu, C; Tang, N; Wang, N	1
Kibble, A; Shumoogam, J; Walker, K	1
Berg, Jv; Kuipers, GK; Lafleur, MV; Slotman, BJ; Sminia, P; Stoter, TR; Wedekind, LE	1
Cai, Y; Gu, Z; Hankinson, O; Hsu, E; Wang, F; Xia, T; Zhang, R	1
Ho, D; Huang, H; Osawa, E; Pierstorff, E	1
Adelman, DC; Bible, K; Heath, EI; Lorusso, PM; Martell, RE	1
Maheshwari, RK; Mathad, VT; Misra, N; Raj, K; Seth, P; Singh, AK; Thangapazham, RL	1
Faivre, S; Le Tourneau, C; Raymond, E	1
Batsuren, D; Kang, K; Kim, CY; Lee, HJ; Lee, SB; Nho, CW; Tunsag, J	1
JAILER, JW	1
Balkman, CE; Engler, KL; Johnson, CS; Muindi, JR; Page, RL; Ramnath, N; Rassnick, KM; Trump, DL; Yu, WD	1
Haroon, F; Keilhoff, G; Krautwald, K; Makarow, P; Schild, L	1
Agapova, LS; Chumakov, PM; Feinstein, E; Frolova, EI; Gudkov, AV; Ilyinskaya, GV; Kochetkov, DV; Komarov, PG; Kovriga, I; Kravchenko, JE; Strom, E	1
Attard, G; Dymond, M; Postle, AD	1
Brugarolas, A; Gosalvez, M	2
Gosálvez, M	2
McCarty, MF	1
Grier, RL; Merkley, DF; Roth, JA	1
Blanco, MF; de Paz, E; Gosálvez, M	1
Hahn, FE	1
Young, CW	1
Lankelma, J; Leyva, A; Penders, PG; Pinedo, HM	1
Benetti, GP; Bombelli, G; Fugazza, L; Illeni, MT; La Vecchia, G; Montalto, F; Stramba Badiale, M; Uslenghi, C	1
Bannister, RM; Barrick, ED; Strauss, ME	1
Pope, D; Sorahan, T	1
Eliason, JF; Kaufmann, F; Tanaka, T; Tsukaguchi, T	1
Aosasa, S; Kinoshita, M; Mochizuki, H; Oda, Y; Ohe, H; Ohkusa, Y; Ono, S; Tamakuma, S	1
Chen, LB; Kawakami, M; Koya, K; Li, Y; Tatsuta, N; Ukai, T; Wang, H	1
Brunelli, BT; Chen, LB; Koya, K; Li, Y; Modica-Napolitano, JS; Weisberg, E	1
O'Neill, WM	1
Auteri, A; Bova, G; Bruni, F; Chiarion, C; Di Renzo, M; Ferrì, P; Girardello, R; Pasqui, AL; Saletti, M	1
Hiscox, S; Jiang, WG	1
Grau, MT; Ortiz, JA; Rives, A; Romero, A; Sacristán, A; Villamayor, F	1
Ali-Osman, F; Srivenugopal, KS	1
Alpert, LC; Batist, G; Chen, X; Griffith, OW; Hayward, MA; Schecter, RL	1
Batist, G; Carystinos, GD; Chen, X	1
Fujimura, S; Hasumi, T; Kobayashi, S; Okada, S; Sato, N	1
Auwerx, J; Fruchart, JC; Gelman, L	1
Chernov, MV; Christov-Tselkov, K; Coon, JS; Gudkov, AV; Komarov, PG; Komarova, EA; Kondratov, RV	1
Braybrooke, JP; Collins, WC; Cramer, JA; Ganesan, TS; Harris, AL; Levitt, NC; Lodi, R; Propper, DJ; Styles, P; Talbot, DC; Taylor, DJ	1
Ferber, D	1
Carrera, CJ; Carson, DA; Cottam, HB; Genini, D; Hamel, E; Leoni, LM; Shih, H	1
Baker, SD; Britten, CD; Collins, W; Cramer, J; Eckhardt, SG; Rothenberg, M; Rowinsky, EK; Smetzer, L; Smith, L; Stephenson, J; Von Hoff, DD; Weiss, GR	1
Gudkov, AV; Komarova, EA	1
Hanafusa, T; Tomita, K	1
Hamilton, L; Jackson, JR; Sorahan, T	1
Berthou, C; Bourge, JF; Denizot, Y; Geromin, D; Sasportes, M; Sigaux, F; Soulié, A; Zhang, Y	1
Hoffman, RM	1
Bergman, B; Brezicka, F; Einbeigi, Z	1
Roberts-Thomson, SJ	1
Holder, JC; Murphy, GJ	1
Lin, H; Longo, DL; Morin, PJ; Sasaki, CY	1
Jing, Z; Niu, Q; Zhao, C	1
Gosálvez Gosálvez, M	1
Wood, I	1
Lin, H; Shen, Y; Wang, Q; Yan, M	1
Cheson, BD; Colevas, AD; West, PJ	1
Dixon, JE; Donner, DB; Durden, DL; Mayo, LD; Tonks, NK	1
Corbett, TH; Luesch, H; Mooberry, SL; Moore, RE; Paul, VJ; Yoshida, WY	1
Alonso-Varona, A; Bilbao, J; Bilbao, P; Castro, B; del Olmo, M; Palomares, T	1
Marra, F; Pastacaldi, S	1
Bradshaw, TD; Browne, HL; Chua, MS; Sausville, EA; Stevens, MF; Trapani, V	1
Habel, F; Hoban, D; Laverdiere, M; Restieri, C	1
Jenssen, HL; Jülich, WD; Köhler, H; Weuffen, W	1
Nieper, HA	1
Arii, K; Hotta, T; Iwahashi, M; Noguchi, K; Tamai, M; Tani, M; Tanimura, H; Tsunoda, T; Yamaue, H	1
Abe, O; Asanuma, F; Ishibiki, K; Kawamura, E; Kubota, T; Suto, A; Suzuki, T; Suzuki, Y; Yamada, T; Yamada, Y	1
Eliason, JF; Kaufmann, F; Ramuz, H	1
DeGraff, W; Friedman, N; Mitchell, JB; Russo, A	1
Lalezari, I; Schwartz, EL	1
Tannenbaum, SR	1
Wattenberg, LW	1
Brugmans, J; Parks, LC; Tripodi, D	1
Churchill, WH; David, JR	1
Tatsuno, I	1

Reviews

72 review(s) available for thiazoles and Benign Neoplasms

Article	Year
Cancer-associated thrombosis - treatment and prevention with direct oral factor Xa inhibitors. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2021,Summer, Volume: 34, Issue:4 Topics: Administration, Oral; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thrombosis; Venous Thromboembolism	2021
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data. Journal of gynecologic oncology, 2022, Volume: 33, Issue:5 Topics: Administration, Oral; Anticoagulants; Heparin; Humans; Japan; Neoplasms; Pulmonary Embolism; Pyridines; Thiazoles; Venous Thromboembolism	2022
Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review). European journal of medicinal chemistry, 2023, Jan-15, Volume: 246 Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Pyrrolidines; Structure-Activity Relationship; Thiazoles	2023
Sulphur Containing Heterocyclic Compounds as Anticancer Agents. Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:8 Topics: Antineoplastic Agents; Heterocyclic Compounds; Humans; Neoplasms; Structure-Activity Relationship; Sulfur; Thiazoles	2023
Synergistic therapeutic potential of alpelisib in cancers (excluding breast cancer): Preclinical and clinical evidences. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 159 Topics: Antineoplastic Agents; Breast Neoplasms; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Neoplasms; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Thiazoles	2023
Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products. Natural product reports, 2020, 05-01, Volume: 37, Issue:5 Topics: Animals; Antineoplastic Agents; Biological Products; DEAD-box RNA Helicases; Epoxy Compounds; Eukaryotic Initiation Factor-4A; Gene Expression Regulation; Humans; Macrolides; Molecular Targeted Therapy; Neoplasms; Protein Biosynthesis; Sterols; Thiazoles	2020
[Direct oral anticoagulants in the treatment of cancer-associated thrombosis]. Revue medicale suisse, 2019, Dec-04, Volume: 15, Issue:674 Topics: Administration, Oral; Anticoagulants; Dalteparin; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyridines; Rivaroxaban; Thiazoles; Venous Thromboembolism	2019
[The role of direct oral anticoagulants in the management of cancer-associated thrombosis in 2020]. Bulletin du cancer, 2020, Volume: 107, Issue:5 Topics: Anticoagulants; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cytochrome P-450 Enzyme System; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Neoplasm Proteins; Neoplasms; Pyrazoles; Pyridines; Pyridones; Recurrence; Rivaroxaban; Secondary Prevention; Thiazoles; Thrombosis; Venous Thromboembolism	2020
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Cancer-associated venous thromboembolism and the non-vitamin K antagonist oral anticoagulants: a review of clinical outcomes and patient perspectives. Expert review of cardiovascular therapy, 2020, Volume: 18, Issue:11 Topics: Administration, Oral; Anticoagulants; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thromboembolism	2020
2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents. European journal of medicinal chemistry, 2021, Jan-15, Volume: 210 Topics: Animals; Antineoplastic Agents; Drug Design; Drug Discovery; Humans; Neoplasms; Protein Kinase Inhibitors; Structure-Activity Relationship; Thiazoles; Tubulin Modulators	2021
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan. Journal of atherosclerosis and thrombosis, 2017, Jun-01, Volume: 24, Issue:6 Topics: Administration, Oral; Anticoagulants; Clinical Trials as Topic; Factor Xa Inhibitors; Hemorrhage; Hospitalization; Humans; Japan; Neoplasms; Outpatients; Platelet Count; Pyrazoles; Pyridines; Pyridones; Recurrence; Rivaroxaban; Thiazoles; Venous Thromboembolism; Warfarin	2017
Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far? Hamostaseologie, 2017, Oct-27, Volume: 37, Issue:4 Topics: Acute Disease; Administration, Oral; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Guideline Adherence; Heparin, Low-Molecular-Weight; Humans; Long-Term Care; Neoplasms; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thromboembolism	2017
Anticancer Potential of Thiazole Derivatives: A Retrospective Review. Mini reviews in medicinal chemistry, 2018, Volume: 18, Issue:8 Topics: Amides; Antineoplastic Agents; DNA Damage; Drug Design; Humans; Imidazoles; Neoplasms; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Thiazoles	2018
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE). Thorax, 2018, Volume: 73, Issue:Suppl 2 Topics: Ambulatory Care; Anticoagulants; Dabigatran; Female; Hemorrhage; Humans; Length of Stay; Male; Neoplasms; Patient Discharge; Patient Selection; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Substance Abuse, Intravenous; Thiazoles	2018
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants. Thrombosis research, 2019, Volume: 177 Topics: Anticoagulants; Clinical Trials as Topic; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyridines; Rivaroxaban; Thiazoles; Venous Thromboembolism	2019
Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues. European journal of medicinal chemistry, 2019, May-15, Volume: 170 Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Disease Progression; Drug Delivery Systems; Drug Discovery; Humans; Intracellular Signaling Peptides and Proteins; Neoplasms; Thiazoles; Thiazolidines; Thiosemicarbazones	2019
Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: New Insights from Randomized Controlled Trials. Drugs, 2019, Volume: 79, Issue:6 Topics: Administration, Oral; Anticoagulants; Benzamides; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism	2019
Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism. Expert opinion on drug safety, 2019, Volume: 18, Issue:4 Topics: Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism	2019
Cost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States. Thrombosis research, 2019, Volume: 180 Topics: Anticoagulants; Cost-Benefit Analysis; Dalteparin; Factor Xa Inhibitors; Humans; Neoplasms; Pyridines; Quality-Adjusted Life Years; Rivaroxaban; Thiazoles; Thrombosis	2019
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis. Journal of the American Heart Association, 2019, 07-16, Volume: 8, Issue:14 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin	2019
Thiazole in the targeted anticancer drug discovery. Future medicinal chemistry, 2019, Volume: 11, Issue:15 Topics: Antineoplastic Agents; Apoptosis; Cyclin-Dependent Kinases; Drug Discovery; ErbB Receptors; Humans; Neoplasms; Phosphatidylinositol 3-Kinases; Structure-Activity Relationship; Thiazoles	2019
[Sphingosine kinase 1 and tumor]. Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:7 Topics: Amino Alcohols; Animals; Apoptosis; Cell Movement; Cell Proliferation; Ceramides; Enzyme Activation; Enzyme Inhibitors; Humans; Lysophospholipids; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Thiazoles	2013
Harnessing the benefits of PPARβ/δ agonists. Life sciences, 2013, Dec-18, Volume: 93, Issue:25-26 Topics: Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Neoplasms; PPAR delta; PPAR-beta; Rodentia; Thiazoles	2013
Tyrosine kinase inhibitors: muco-cutaneous side effects at the microscope. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2014, Volume: 149, Issue:3 Topics: Antineoplastic Agents; Benzamides; Biopsy; Dasatinib; Exanthema; Humans; Imatinib Mesylate; Microscopy, Electron; Neoplasms; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles	2014
Direct oral anticoagulants in the management of venous thromboembolism--evidence from major clinical trials. Seminars in hematology, 2014, Volume: 51, Issue:2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thromboembolism	2014
Small molecule inhibitors in veterinary oncology practice. The Veterinary clinics of North America. Small animal practice, 2014, Volume: 44, Issue:5 Topics: Animals; Benzamides; Cat Diseases; Cats; Dog Diseases; Dogs; Indoles; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrroles; Thiazoles	2014
Cancer-associated thrombosis: investigating the role of new oral anticoagulants. Thrombosis research, 2015, Volume: 135, Issue:5 Topics: Administration, Oral; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyridines; Randomized Controlled Trials as Topic; Recurrence; Thiazoles; Thrombin; Venous Thromboembolism	2015
A functional perspective of nitazoxanide as a potential anticancer drug. Mutation research, 2014, Volume: 768 Topics: Animals; Antineoplastic Agents; Antiparasitic Agents; Cell Proliferation; Cell Survival; Humans; Neoplasms; Nitro Compounds; Proto-Oncogene Proteins c-myc; Signal Transduction; Stromal Cells; Thiazoles; Unfolded Protein Response	2014
Recent Patents on Thiazole Derivatives Endowed with Antitumor Activity. Recent patents on anti-cancer drug discovery, 2015, Volume: 10, Issue:3 Topics: Animals; Antineoplastic Agents; Drug Discovery; Humans; Matrix Metalloproteinases; Neoplasms; Patents as Topic; Structure-Activity Relationship; Thiazoles	2015
Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence. Biochemical Society transactions, 2015, Volume: 43, Issue:6 Topics: Epoxy Compounds; Eukaryotic Initiation Factor-4A; Gene Expression Regulation, Neoplastic; Humans; Macrolides; Molecular Targeted Therapy; Neoplasms; Protein Biosynthesis; Protein Isoforms; Sterols; Thiazoles; Triterpenes	2015
Overview of CDK9 as a target in cancer research. Cell cycle (Georgetown, Tex.), 2016, Volume: 15, Issue:4 Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cyclic N-Oxides; Cyclin-Dependent Kinase 9; Flavonoids; Humans; Indolizines; Molecular Targeted Therapy; Neoplasms; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; Pyrazoles; Pyridinium Compounds; Roscovitine; Thiazoles; Urea	2016
Targeting translation: eIF4E as an emerging anticancer drug target. Expert reviews in molecular medicine, 2016, Jan-18, Volume: 18 Topics: Animals; Antineoplastic Agents; Cyclin D1; Epoxy Compounds; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Macrolides; Neoplasms; Oligonucleotides, Antisense; Protein Biosynthesis; Ribavirin; RNA, Small Interfering; Signal Transduction; Sirolimus; Survivin; Thiazoles; Triterpenes; Vascular Endothelial Growth Factor A	2016
[Proteasome inhibitors in cancer therapy]. Postepy higieny i medycyny doswiadczalnej (Online), 2015, Dec-31, Volume: 69 Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Caspases; Dipeptides; Humans; Lactones; Multiple Myeloma; Neoplasms; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Pyrroles; Thiazoles; Threonine	2015
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients. Advances in experimental medicine and biology, 2017, Volume: 906 Topics: Administration, Oral; Anticoagulants; Antithrombins; Catheters, Indwelling; Dabigatran; Drug Administration Schedule; Drug Dosage Calculations; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2017
The IAP Protein Family, SMAC Mimetics and Cancer Treatment. Critical reviews in oncogenesis, 2016, Volume: 21, Issue:3-4 Topics: Antineoplastic Agents; Apoptosis; Azocines; Benzhydryl Compounds; Cell Proliferation; Dipeptides; Humans; Indoles; Inhibitor of Apoptosis Proteins; Neoplasms; Thiazoles	2016
SNS-595, a naphthyridine cell cycle inhibitor and stimulator of apoptosis for the treatment of cancers. Current opinion in investigational drugs (London, England : 2000), 2008, Volume: 9, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contraindications; Humans; Naphthyridines; Neoplasms; Patents as Topic; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Thiazoles	2008
A naturally occurring cancer with molecular connectivity to human diseases. Cell cycle (Georgetown, Tex.), 2008, Volume: 7, Issue:15 Topics: Animal Diseases; Animals; Antineoplastic Agents; Apoptosis; Brachyura; Disease; Disease Models, Animal; DNA Damage; Drug Evaluation, Preclinical; HSP70 Heat-Shock Proteins; Humans; Molecular Sequence Data; Neoplasms; Pyridines; Signal Transduction; Thiazoles; Tumor Suppressor Protein p53	2008
Targeting cancer cells by synthetic lethality: autophagy and VHL in cancer therapeutics. Cell cycle (Georgetown, Tex.), 2008, Volume: 7, Issue:19 Topics: Animals; Autophagy; Genes, Lethal; Humans; Models, Biological; Neoplasms; Proto-Oncogene Proteins c-ret; Pyridines; Thiazoles; Von Hippel-Lindau Tumor Suppressor Protein	2008
Aurora kinase inhibitors as anti-cancer therapy. Anti-cancer drugs, 2010, Volume: 21, Issue:4 Topics: Antineoplastic Agents; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Benzamides; Benzimidazoles; Cyclohexanecarboxylic Acids; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Neoplasms; Organophosphates; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Quinazolines; Thiazoles; Urea	2010
A new target for proteasome inhibitors: FoxM1. Expert opinion on investigational drugs, 2010, Volume: 19, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Drug Delivery Systems; Forkhead Box Protein M1; Forkhead Transcription Factors; Humans; Models, Biological; Neoplasms; Proteasome Inhibitors; Thiazoles	2010
Dasatinib in solid tumors. Expert opinion on investigational drugs, 2010, Volume: 19, Issue:3 Topics: Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dasatinib; Humans; Neoplasm Metastasis; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles	2010
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors. Cancer treatment reviews, 2010, Volume: 36, Issue:6 Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Dasatinib; Humans; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles	2010
Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide. Marine drugs, 2010, Mar-31, Volume: 8, Issue:4 Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Epoxy Compounds; Humans; Lactones; Macrolides; Microtubules; Neoplasms; Porifera; Pyrans; Thiazoles	2010
Novel dual Src/Abl inhibitors for hematologic and solid malignancies. Expert opinion on investigational drugs, 2010, Volume: 19, Issue:8 Topics: Aniline Compounds; Animals; Antineoplastic Agents; Benzodioxoles; Clinical Trials as Topic; CSK Tyrosine-Protein Kinase; Dasatinib; Dogs; Drug Evaluation, Preclinical; Fusion Proteins, bcr-abl; Hematologic Neoplasms; Humans; Mice; Mice, Knockout; Mice, Nude; Mice, SCID; Neoplasms; Nitriles; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolines; Rats; src-Family Kinases; Thiazoles; Triazines	2010
Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy. Cancer letters, 2013, May-28, Volume: 332, Issue:2 Topics: Alkaloids; Alkanes; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Aquatic Organisms; Biological Products; Bryostatins; Carbamates; Cell Proliferation; Depsipeptides; Dioxoles; Drug Screening Assays, Antitumor; Humans; Lactones; Macrolides; Microtubules; Models, Chemical; Neoplasms; Phenanthrolines; Phenazines; Proteasome Endopeptidase Complex; Pyrones; Pyrroles; Quinolines; Spiro Compounds; Steroids; Tetrahydroisoquinolines; Thiazoles; Trabectedin	2013
[SRC kinases in tumor therapy]. Medizinische Klinik (Munich, Germany : 1983), 2010, Volume: 105, Issue:10 Topics: Aniline Compounds; Benzodioxoles; Cell Physiological Phenomena; Cell Transformation, Neoplastic; Clinical Trials, Phase II as Topic; Dasatinib; Disease Progression; DNA Mutational Analysis; Drug Delivery Systems; Enzyme Activation; Humans; Neoplasms; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrimidines; Quinazolines; Quinolines; src-Family Kinases; Thiazoles	2010
Dasatinib: an anti-tumour agent via Src inhibition. Current drug targets, 2011, Volume: 12, Issue:4 Topics: Animals; Antineoplastic Agents; Dasatinib; Drug Delivery Systems; Humans; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles	2011
Inhibitors of translation initiation as cancer therapeutics. Future medicinal chemistry, 2009, Volume: 1, Issue:9 Topics: Antineoplastic Agents; Epoxy Compounds; Eukaryotic Initiation Factor-4A; Eukaryotic Initiation Factor-4E; Humans; Hydrazones; Macrolides; Neoplasms; Nitro Compounds; Oligonucleotides, Antisense; Protein Biosynthesis; Sterols; Thiazoles; Triterpenes	2009
Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis. Future medicinal chemistry, 2011, Volume: 3, Issue:3 Topics: Benzamides; Dasatinib; Drug Discovery; Imatinib Mesylate; Inflammation; Models, Molecular; Molecular Conformation; Neoplasms; Patents as Topic; Phosphotransferases; Piperazines; Protein Binding; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Thiazoles	2011
Current status of SRC inhibitors in solid tumor malignancies. The oncologist, 2011, Volume: 16, Issue:5 Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzodioxoles; Clinical Trials as Topic; Dasatinib; Dose-Response Relationship, Drug; Humans; Neoplasms; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines; src-Family Kinases; Thiazoles	2011
[Indications and current development of new targeted therapies in pediatric oncology]. Bulletin du cancer, 2011, Volume: 98, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Benzenesulfonates; Bevacizumab; Child; Dasatinib; Erlotinib Hydrochloride; Hedgehog Proteins; Humans; Imatinib Mesylate; Indoles; Integrins; Molecular Targeted Therapy; Neoplasms; Niacinamide; Nifurtimox; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thiazoles; TOR Serine-Threonine Kinases	2011
Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Sep-01, Volume: 17, Issue:17 Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dasatinib; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; src-Family Kinases; Thiazoles; Tumor Microenvironment	2011
Targeted drug therapy: the platelet side. Platelets, 2011, Volume: 22, Issue:7 Topics: Animals; Blood Platelets; Dasatinib; Humans; Molecular Targeted Therapy; Neoplasms; Platelet Activation; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Thiazoles	2011
Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy. Veterinary and comparative oncology, 2012, Volume: 10, Issue:3 Topics: Animals; Antineoplastic Agents; Benzamides; Drug Therapy, Combination; Humans; Indoles; Neoplasms; Piperidines; Pyridines; Pyrroles; Receptor Protein-Tyrosine Kinases; Thiazoles	2012
Evidence for therapeutic drug monitoring of targeted anticancer therapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-10, Volume: 30, Issue:32 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Area Under Curve; Benzamides; Benzenesulfonates; Cetuximab; Dasatinib; Drug Monitoring; Everolimus; Evidence-Based Medicine; Half-Life; Humans; Imatinib Mesylate; Indoles; Injections, Intravenous; Molecular Targeted Therapy; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Rituximab; Sirolimus; Sorafenib; Sunitinib; Thiazoles	2012
Do selective cyclo-oxygenase inhibitors eliminate the adverse events associated with nonsteroidal anti-inflammatory drug therapy? European journal of gastroenterology & hepatology, 2002, Volume: 14 Suppl 1 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Meloxicam; Neoplasms; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2002
Mining the NCI screening database: explorations of agents involved in cell cycle regulation. Progress in cell cycle research, 2003, Volume: 5 Topics: Animals; Antineoplastic Agents; Benzothiazoles; Cell Cycle Proteins; Cytochrome P-450 CYP1A1; Databases as Topic; Drug Screening Assays, Antitumor; Humans; National Institutes of Health (U.S.); Neoplasms; Thiazoles; United States	2003
Therapeutic potential of thiazolidinediones as anticancer agents. Expert opinion on investigational drugs, 2003, Volume: 12, Issue:12 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Neoplasms; Thiazoles	2003
Drugging cell cycle kinases in cancer therapy. Current drug targets, 2005, Volume: 6, Issue:3 Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding Sites; Cyclin-Dependent Kinases; Flavonoids; Humans; Neoplasms; Oxazoles; Piperidines; Protein Kinase Inhibitors; Purines; Roscovitine; Staurosporine; Sulfonamides; Thiazoles	2005
The when and wheres of CDC25 phosphatases. Current opinion in cell biology, 2006, Volume: 18, Issue:2 Topics: Animals; Benzoquinones; cdc25 Phosphatases; Cell Cycle; Cell Cycle Proteins; Humans; Isoenzymes; Models, Biological; Naphthoquinones; Neoplasms; Quinolones; Quinones; Thiazoles	2006
New developments in multitargeted therapy for patients with solid tumours. Cancer treatment reviews, 2008, Volume: 34, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzenesulfonates; Clinical Trials as Topic; Dasatinib; Drug Delivery Systems; Humans; Imatinib Mesylate; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Sunitinib; Thiazoles	2008
Cytostatic and reverse-transforming therapies of cancer - a brief review and future prospects. Medical hypotheses, 1982, Volume: 8, Issue:6 Topics: Animals; Antineoplastic Agents; Benzaldehydes; Cell Transformation, Neoplastic; Cyclic AMP; Growth Inhibitors; Humans; Interferons; Neoplasms; Protease Inhibitors; Solvents; Thiazoles; Thiazolidines; Vitamin A	1982
Potential for selective modulation of glutathione in cancer chemotherapy. Chemico-biological interactions, 1998, Apr-24, Volume: 111-112 Topics: Animals; Buthionine Sulfoximine; Cell Communication; Drug Resistance; Enzyme Inhibitors; Female; Gap Junctions; Glutamate-Cysteine Ligase; Glutathione; Humans; Mammary Neoplasms, Experimental; Neoplasms; Prodrugs; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Thiazoles; Thiazolidines	1998
An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cellular and molecular life sciences : CMLS, 1999, Volume: 55, Issue:6-7 Topics: Adipocytes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Cycle; Cell Differentiation; Cell Transformation, Neoplastic; Colonic Neoplasms; Energy Metabolism; Fatty Acids; Gene Expression Regulation; Homeostasis; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Intestinal Mucosa; Lipid Metabolism; Macrophages; Neoplasms; Peroxisome Proliferators; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Thiazoles; Transcription Factors	1999
Suppression of p53: a new approach to overcome side effects of antitumor therapy. Biochemistry. Biokhimiia, 2000, Volume: 65, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Mice; Mice, Transgenic; Neoplasms; Thiazoles; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2000
[PPARs, cancer cells and inflammation]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cytokines; Humans; Inflammation; Neoplasms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors	2000
Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment. Immunology and cell biology, 2000, Volume: 78, Issue:4 Topics: Animals; Cell Cycle; Cell Differentiation; Colonic Neoplasms; Humans; Lipid Metabolism; Liver Neoplasms; Neoplasms; Nuclear Proteins; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors	2000
PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends in pharmacological sciences, 2000, Volume: 21, Issue:12 Topics: Animals; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Humans; Inflammation; Ligands; Neoplasms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors	2000
[Thiazolidinediones and PPARgamma system in repair of liver damage]. Recenti progressi in medicina, 2002, Volume: 93, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antioxidants; Arteriosclerosis; Chromans; Diabetes Mellitus, Type 2; Eicosanoids; Fatty Acids; Forecasting; Humans; Hypoglycemic Agents; In Vitro Techniques; Inflammation; Liver Cirrhosis; Neoplasms; Obesity; Receptors, Cytoplasmic and Nuclear; Research; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone	2002
Diet and exposure to N-nitroso compounds. Princess Takamatsu symposia, 1985, Volume: 16 Topics: Bacteria; Diet; Food; Humans; Neoplasms; Nitrates; Nitrites; Nitrosamines; Nitroso Compounds; Thiazoles; Thiazolidines	1985

Trials

35 trial(s) available for thiazoles and Benign Neoplasms

Article	Year
A phase I study of LCL161, a novel oral pan-inhibitor of apoptosis protein (IAP) antagonist, in Japanese patients with advanced solid tumors. Asia-Pacific journal of clinical oncology, 2022, Volume: 18, Issue:5 Topics: Bayes Theorem; Humans; Inhibitor of Apoptosis Proteins; Japan; Neoplasms; Paclitaxel; Thiazoles; Treatment Outcome	2022
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study. European journal of cancer (Oxford, England : 1990), 2021, Volume: 151 Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Europe; Everolimus; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Thiazoles; Treatment Outcome; United States	2021
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism. The New England journal of medicine, 2018, Feb-15, Volume: 378, Issue:7 Topics: Adult; Aged; Anticoagulants; Dalteparin; Follow-Up Studies; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Pyridines; Recurrence; Thiazoles; Venous Thromboembolism	2018
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients. Thrombosis and haemostasis, 2018, Volume: 118, Issue:1 Topics: Aged; Anticoagulants; Blood Transfusion; Double-Blind Method; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Odds Ratio; Prospective Studies; Pyridines; Rivaroxaban; Thiazoles; Venous Thromboembolism	2018
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study. Thrombosis and haemostasis, 2018, Volume: 118, Issue:8 Topics: Aged; Anticoagulants; Clinical Decision-Making; Dalteparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Patient Selection; Pyridines; Recurrence; Risk Assessment; Risk Factors; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Venous Thromboembolism	2018
Phase I study of alpelisib (BYL719), an α-specific PI3K inhibitor, in Japanese patients with advanced solid tumors. Cancer science, 2019, Volume: 110, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Asian People; Female; Humans; Male; Middle Aged; Mutation; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Progression-Free Survival; Protein Kinase Inhibitors; Thiazoles; Young Adult	2019
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study. Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:11 Topics: Aged; Blood Coagulation; Dalteparin; Drug Administration Schedule; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Pulmonary Embolism; Pyridines; Recurrence; Risk Factors; Thiazoles; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2019
Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies. British journal of clinical pharmacology, 2014, Volume: 78, Issue:3 Topics: Adult; Aged; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Nonlinear Dynamics; Phosphoinositide-3 Kinase Inhibitors; Thiazoles; Tissue Distribution	2014
Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-01, Volume: 32, Issue:28 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Biological Availability; Cytokines; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Inhibitor of Apoptosis Proteins; Male; Middle Aged; Nausea; Neoplasms; Pharmaceutical Solutions; Syndrome; Tablets; Thiazoles; Treatment Outcome; Vomiting	2014
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adult; Anticoagulants; Dalteparin; Double-Blind Method; Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasms; Prospective Studies; Pulmonary Embolism; Pyridines; Recurrence; Research Design; Sample Size; Thiazoles; Time Factors; Treatment Outcome; Venous Thrombosis	2015
A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors. Investigational new drugs, 2016, Volume: 34, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Aurora Kinase A; Cross-Over Studies; Cyclohexanecarboxylic Acids; Docetaxel; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Taxoids; Thiazoles	2016
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol. International journal of clinical oncology, 2016, Volume: 21, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Febuxostat; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Neoplasms; Thiazoles; Tumor Lysis Syndrome; Uric Acid; Xanthine Oxidase; Young Adult	2016
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial. The Lancet. Haematology, 2016, Volume: 3, Issue:8 Topics: Aged; Double-Blind Method; Equivalence Trials as Topic; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Prognosis; Pyridines; Survival Rate; Thiazoles; Venous Thromboembolism	2016
Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II. Investigational new drugs, 2017, Volume: 35, Issue:4 Topics: Adult; Aged; Biotransformation; Carbon Radioisotopes; Feces; Female; Humans; Injections, Intravenous; Male; Middle Aged; Naphthyridines; Neoplasms; Thiazoles; Topoisomerase II Inhibitors	2017
Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Oct-01, Volume: 15, Issue:19 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dasatinib; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pyrimidines; Thiazoles; Treatment Outcome	2009
Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors. Cancer, 2010, Mar-15, Volume: 116, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Administration Schedule; Drug Interactions; Electrocardiography; Female; Heart; Humans; Ketoconazole; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Thiazoles	2010
Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-01, Volume: 16, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Naphthyridines; Neoplasms; Quinolones; Recurrence; Thiazoles; Treatment Outcome; Young Adult	2010
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Dasatinib; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hematologic Neoplasms; Hospitals, Pediatric; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Maximum Tolerated Dose; Neoplasms; Patient Selection; Pediatrics; Philadelphia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Risk Assessment; Thiazoles; Treatment Outcome; Young Adult	2011
Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors. Cancer science, 2011, Volume: 102, Issue:11 Topics: Aged; Anorexia; Antineoplastic Agents; Biomarkers; Bone Resorption; Dasatinib; Dose-Response Relationship, Drug; Fatigue; Female; Gastrointestinal Diseases; Humans; Japan; Magnesium; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Proteins; Neoplasms; Osteoclasts; Pleural Effusion; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; src-Family Kinases; Thiazoles	2011
Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies. Investigational new drugs, 2012, Volume: 30, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Dasatinib; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Thiazoles; Transforming Growth Factor alpha	2012
Phase I trial of dasatinib and ixabepilone in patients with solid tumors. Investigational new drugs, 2013, Volume: 31, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Epothilones; Female; Humans; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Tubulin Modulators	2013
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors. Investigational new drugs, 2013, Volume: 31, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Dasatinib; Demography; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Interleukin-8; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Neoplastic Cells, Circulating; Pyrimidines; Thiazoles; Young Adult	2013
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors. Investigational new drugs, 2008, Volume: 26, Issue:1 Topics: Administration, Oral; Adult; Aged; Anemia; Angiogenesis Inhibitors; Area Under Curve; Biological Availability; CDC2-CDC28 Kinases; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Oxazoles; Radiotherapy, Adjuvant; Thiazoles; Time Factors; Treatment Outcome	2008
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:5 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Calcitriol; Cell Line, Tumor; Cisplatin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Hypersensitivity; Gastrointestinal Diseases; Hematologic Diseases; Injections, Intravenous; Neoplasms; Tetrazolium Salts; Thiazoles; Vitamins	2008
Reversal of cancer. Lancet (London, England), 1983, Apr-09, Volume: 1, Issue:8328 Topics: Antineoplastic Agents; Bucladesine; Cell Differentiation; Clinical Trials as Topic; Humans; Neoplasms; Thiazoles; Thiazolidines	1983
Thiazolidine-4-carboxylic acid, a selective drug against human cancers. Die Naturwissenschaften, 1980, Volume: 67, Issue:6 Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Humans; Lethal Dose 50; Male; Mice; Neoplasms; Neoplasms, Experimental; Thiazoles; Thiazolidines	1980
Preliminary clinical results with norgamem (thioproline) and revercan (2-amino-2-thiazoline): the first inducers of reverse transformation. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1982, Volume: 80 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Clinical Trials as Topic; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms; Thiazoles; Thiazolidines; Urinary Bladder Neoplasms	1982
Lessons of the laetrile study. Clinical bulletin, 1981, Volume: 11, Issue:3 Topics: Amygdalin; Attitude; Benzaldehydes; Clinical Trials as Topic; Complementary Therapies; Humans; Neoplasms; Philosophy; Politics; Quackery; Research Design; Thiazoles; Thiazolidines; United States	1981
Ex vivo evaluation of pidotimod activity on cell-mediated immunity. Arzneimittel-Forschung, 1994, Volume: 44, Issue:12A Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; CD3 Complex; Double-Blind Method; Female; Humans; Immunity, Cellular; Lymphocyte Count; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Pyrrolidonecarboxylic Acid; Stimulation, Chemical; T-Lymphocytes; Thiazoles; Thiazolidines	1994
The cognitive and psychomotor effects of opioid drugs in cancer pain management. Cancer surveys, 1994, Volume: 21 Topics: Adult; Amphetamines; Analgesics, Opioid; Buprenorphine; Central Nervous System Stimulants; Chronic Disease; Cocaine; Codeine; Cognition; Dextropropoxyphene; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Morphine; Neoplasms; Pain; Psychomotor Performance; Randomized Controlled Trials as Topic; Reaction Time; Thiazoles	1994
Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Mitochondria; Neoplasm Staging; Neoplasms; Pyridines; Severity of Illness Index; Thiazoles; Treatment Outcome	1999
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Magnesium; Male; Metabolic Clearance Rate; Middle Aged; Mitochondria; Neoplasms; Proteinuria; Pyridines; Thiazoles; Tissue Distribution	2000
[MTT assay using fresh surgical specimens with reference to the transfer system and reproducibility in "test center" method]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Coloring Agents; Drug Screening Assays, Antitumor; Female; Hospital Shared Services; Humans; Japan; Laboratories, Hospital; Male; Middle Aged; Neoplasms; Reproducibility of Results; Specimen Handling; Tetrazolium Salts; Thiazoles	1990

Other Studies

313 other study(ies) available for thiazoles and Benign Neoplasms

Article	Year
Molecular docking, 3D-QASR and molecular dynamics simulations of thiazoles Pin1 inhibitors. Journal of biomolecular structure & dynamics, 2022, Volume: 40, Issue:23 Topics: Carcinogenesis; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Quantitative Structure-Activity Relationship; Thiazoles	2022
Remodelin, a N-acetyltransferase 10 (NAT10) inhibitor, alters mitochondrial lipid metabolism in cancer cells. Journal of cellular biochemistry, 2021, Volume: 122, Issue:12 Topics: HCT116 Cells; Humans; Hydrazones; Lipid Metabolism; MCF-7 Cells; Mitochondria; N-Terminal Acetyltransferases; Neoplasm Proteins; Neoplasms; Thiazoles	2021
Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin. Scientific reports, 2021, 11-18, Volume: 11, Issue:1 Topics: A549 Cells; Anti-Bacterial Agents; Anti-Infective Agents; Caco-2 Cells; Cannabidiol; Cannabinoids; Cannabis; Cell Line, Tumor; Cell Membrane; DNA; DNA Damage; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Free Radicals; Hep G2 Cells; Humans; Inhibitory Concentration 50; Neoplasms; Staphylococcus aureus; Tetrazolium Salts; Thiazoles	2021
Nitazoxanide and Cancer Drug Resistance: Targeting Wnt/β-catenin Signaling Pathway. Archives of medical research, 2022, Volume: 53, Issue:3 Topics: Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasms; Nitro Compounds; Thiazoles; Wnt Signaling Pathway	2022
Design, Synthesis and Cytotoxicity of Thiazole-Based Stilbene Analogs as Novel DNA Topoisomerase IB Inhibitors. Molecules (Basel, Switzerland), 2022, Feb-02, Volume: 27, Issue:3 Topics: Antineoplastic Agents; Drug Design; HCT116 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Neoplasms; Stilbenes; Thiazoles; Topoisomerase Inhibitors	2022
Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, Volume: 36, Issue:5 Topics: Benzamides; Cyclin D1; Down-Regulation; Enzyme Inhibitors; Holoenzymes; Humans; Neoplasms; Ribonucleotide Reductases; Thiazoles; Ubiquitin Thiolesterase; Ubiquitin-Specific Proteases	2022
Safety and Effectiveness of Perospirone in Comparison to Risperidone for Treatment of Delirium in Patients with Advanced Cancer: A Multicenter Prospective Observational Study in Real-World Psycho-Oncology Settings. Acta medica Okayama, 2022, Volume: 76, Issue:2 Topics: Aged; Antipsychotic Agents; Delirium; Humans; Isoindoles; Neoplasms; Psycho-Oncology; Risperidone; Thiazoles	2022
Novel Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:3 Topics: Amides; Antineoplastic Agents; Fluorouracil; Humans; Neoplasms; Thiadiazoles; Thiazoles	2023
Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors. Medical oncology (Northwood, London, England), 2022, Sep-30, Volume: 39, Issue:12 Topics: Animals; Aurora Kinase A; Cell Line, Tumor; Humans; Mammals; Molecular Docking Simulation; Neoplasms; Piperazines; Serine; Thiazoles; Threonine	2022
Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents. Molecules (Basel, Switzerland), 2022, Sep-21, Volume: 27, Issue:19 Topics: Antineoplastic Agents; Benzoic Acid; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esters; Humans; Leukemia; Molecular Structure; Neoplasms; Pyridines; Structure-Activity Relationship; Thiazoles	2022
Synthesis and evaluation of novel thiazole moiety-containing compounds as antibreast cancer agents. Anti-cancer drugs, 2023, 04-01, Volume: 34, Issue:4 Topics: Animals; Antineoplastic Agents; Ki-67 Antigen; Mice; Molecular Docking Simulation; Neoplasms; Receptors, Estrogen; Structure-Activity Relationship; Thiadiazoles; Thiazoles	2023
2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth. Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5 Topics: Amination; Amino Acid Oxidoreductases; Animals; Antineoplastic Agents; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred BALB C; Models, Molecular; Neoplasms; Protein-Lysine 6-Oxidase; Rats; Sulfinic Acids; Thiazoles	2020
Ce6-C6-TPZ co-loaded albumin nanoparticles for synergistic combined PDT-chemotherapy of cancer. Journal of materials chemistry. B, 2019, 10-14, Volume: 7, Issue:38 Topics: Animals; Cattle; Cell Line, Tumor; Cell Survival; Chlorophyllides; Coumarins; Humans; Light; Liver; Mice; Microscopy, Confocal; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Serum Albumin, Bovine; Thiazoles; Tirapazamine; Transplantation, Homologous	2019
Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice. BMC cancer, 2019, Sep-14, Volume: 19, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclohexanes; Disease Models, Animal; Humans; Magnetic Resonance Imaging; Mice; Neoplasms; Positron-Emission Tomography; Pyrroles; Thiazoles; Xenograft Model Antitumor Assays	2019
A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3. The Journal of biological chemistry, 2019, 11-15, Volume: 294, Issue:46 Topics: Allosteric Regulation; Animals; Antineoplastic Agents; Cell Line, Tumor; Diterpenes, Kaurane; Female; Humans; Mice, Inbred BALB C; Models, Molecular; Neoplasms; Ovarian Neoplasms; STAT3 Transcription Factor; Thiazoles	2019
Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells. The Journal of biological chemistry, 2019, 11-15, Volume: 294, Issue:46 Topics: AMP-Activated Protein Kinases; Apoptosis; Cell Line; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Humans; Macrolides; Neoplasms; Phosphorylation; Reactive Oxygen Species; Thiazoles; Vacuolar Proton-Translocating ATPases	2019
First Attempts of the Use of Molecules (Basel, Switzerland), 2019, Nov-02, Volume: 24, Issue:21 Topics: Coordination Complexes; Crystallography, X-Ray; Humans; Ligands; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Molecular; Neoplasms; Oxidation-Reduction; Platinum; Thiazoles; Water	2019
Double Science (New York, N.Y.), 2019, 11-08, Volume: 366, Issue:6466 Topics: Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Drug Resistance, Neoplasm; Female; Humans; Mutation; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Protein Domains; Thiazoles	2019
One-pot synthesis of thiazolo[3,2-a]pyrimidine derivatives, their cytotoxic evaluation and molecular docking studies. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2020, Apr-15, Volume: 231 Topics: A549 Cells; Antineoplastic Agents; Cell Survival; Chemistry Techniques, Synthetic; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; HeLa Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Neoplasms; Pyrimidines; Thiazoles	2020
Investigation of the mechanism of action of a potent pateamine A analog, des-methyl, des-amino pateamine A (DMDAPatA). Biochemistry and cell biology = Biochimie et biologie cellulaire, 2020, Volume: 98, Issue:4 Topics: Adenosine Triphosphatases; Biological Products; Cell Line; Cell Proliferation; Epoxy Compounds; Eukaryotic Initiation Factor-4A; Humans; Macrolides; Neoplasms; Recombinant Proteins; RNA, Messenger; Thiazoles	2020
A comparative study of small molecules targeting eIF4A. RNA (New York, N.Y.), 2020, Volume: 26, Issue:5 Topics: Antineoplastic Agents; Benzofurans; Cell Proliferation; Cell Survival; Epoxy Compounds; Eukaryotic Initiation Factor-4A; Eukaryotic Initiation Factor-4F; Humans; Macrolides; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Small Molecule Libraries; Sterols; Thiazoles; TOR Serine-Threonine Kinases	2020
Tumor-targeting and redox-sensitive micelles based on hyaluronic acid conjugate for delivery of paclitaxel. Journal of biomaterials applications, 2020, Volume: 34, Issue:10 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disulfides; Drug Delivery Systems; Hemolysis; Humans; Hyaluronic Acid; In Vitro Techniques; MCF-7 Cells; Mice; Micelles; Microscopy, Electron, Transmission; Neoplasms; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; Polymers; Rabbits; Tetrazolium Salts; Thiazoles; X-Ray Diffraction	2020
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study. The American journal of medicine, 2020, Volume: 133, Issue:8 Topics: Administration, Oral; Adult; Age Distribution; Aged; Anticoagulants; Asia; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus; Europe; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Hypertension; Latin America; Male; Middle Aged; Middle East; Neoplasms; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Wounds and Injuries	2020
Remodelin, an inhibitor of NAT10, could suppress hypoxia-induced or constitutional expression of HIFs in cells. Molecular and cellular biochemistry, 2020, Volume: 472, Issue:1-2 Topics: Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Hydrazones; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; N-Terminal Acetyltransferases; Neoplasm Invasiveness; Neoplasms; Thiazoles; Tumor Cells, Cultured	2020
Rationally Designed Polypharmacology: α-Helix Mimetics as Dual Inhibitors of the Oncoproteins Mcl-1 and HDM2. ChemMedChem, 2020, 09-16, Volume: 15, Issue:18 Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Design; Humans; Isoxazoles; Molecular Structure; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Protein Binding; Protein Conformation, alpha-Helical; Proto-Oncogene Proteins c-mdm2; Pyrazoles; Structure-Activity Relationship; Thiazoles	2020
[Antithrombotic Treatment of Pulmonary Embolism]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:14 Topics: Acute Disease; Dalteparin; Dose-Response Relationship, Drug; Drug Administration Schedule; Fibrinolytic Agents; Fondaparinux; Guideline Adherence; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Long-Term Care; Neoplasms; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Recurrence; Risk Assessment; Risk Factors; Rivaroxaban; Thiazoles	2020
Cost-effectiveness of edoxaban vs low-molecular-weight heparin and warfarin for cancer-associated thrombosis in Brazil. Thrombosis research, 2020, Volume: 196 Topics: Anticoagulants; Brazil; Cost-Benefit Analysis; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyridines; Quality-Adjusted Life Years; Thiazoles; Thrombosis; Warfarin	2020
A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder. Current medical research and opinion, 2021, Volume: 37, Issue:5 Topics: Acetanilides; Female; Humans; Male; Muscarinic Antagonists; Neoplasms; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents	2021
Development and progression of proteinuria in dogs treated with masitinib for neoplasia: 28 cases (2010-2019). The Journal of small animal practice, 2021, Volume: 62, Issue:8 Topics: Animals; Benzamides; Creatinine; Dog Diseases; Dogs; Neoplasms; Piperidines; Proteinuria; Pyridines; Thiazoles	2021
Fluorinated thiazolidinol drives autophagic cell death in pancreatic cancer cells via AMPK activation and perturbation of critical sentinels of oncogenic signaling. Chemico-biological interactions, 2021, Jul-01, Volume: 343 Topics: AMP-Activated Protein Kinases; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Autophagic Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Enzyme Activation; Female; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Signaling System; Mice, Nude; Neoplasms; Thiazoles; Xenograft Model Antitumor Assays	2021
Comparison of Virosome vs. Liposome as drug delivery vehicle using HepG2 and CaCo2 cell lines. Journal of microencapsulation, 2021, Volume: 38, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Caco-2 Cells; Cell Movement; Curcumin; Drug Delivery Systems; Excipients; Hep G2 Cells; Humans; Liposomes; Microbial Sensitivity Tests; Neoplasms; Nitric Oxide; Tetrazolium Salts; Thiazoles; Virosomes; Wound Healing	2021
Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2021, Volume: 163 Topics: Animals; Cancer Vaccines; Delayed-Action Preparations; Dendritic Cells; Disease Models, Animal; Drug Carriers; Drug Screening Assays, Antitumor; eIF-2 Kinase; Female; Fibroblasts; Hep G2 Cells; Humans; Indoles; Injections, Subcutaneous; Mice; Nanoparticles; Neoplasms; NIH 3T3 Cells; RNA, Messenger; Silicon Dioxide; Thiazoles	2021
Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia. Cells, 2021, 04-26, Volume: 10, Issue:5 Topics: Animals; Body Weight; Cachexia; Cell Differentiation; Cell Proliferation; Culture Media, Conditioned; Glycogen Synthase Kinase 3 beta; Inflammation; Lipopolysaccharides; Lithium Chloride; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Neoplasms; RAW 264.7 Cells; RNA, Small Interfering; Sepsis; SKP Cullin F-Box Protein Ligases; Tetrazolium Salts; Thiazoles	2021
Cancer Selective Target Degradation by Folate-Caged PROTACs. Journal of the American Chemical Society, 2021, 05-19, Volume: 143, Issue:19 Topics: Antineoplastic Agents; Enzyme Inhibitors; Folic Acid; Humans; Ligands; Molecular Structure; Neoplasms; Proteolysis; Pyrrolidines; Thiazoles; Ubiquitin-Protein Ligases	2021
Synthesis and biological evaluation of largazole zinc-binding group analogs. Bioorganic & medicinal chemistry, 2017, 06-15, Volume: 25, Issue:12 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Depsipeptides; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; Molecular Docking Simulation; Neoplasms; Structure-Activity Relationship; Thiazoles; Zinc	2017
Evaluation of Direct-Acting Oral Anticoagulant Use in Patients With Cancer. Journal of pharmacy practice, 2018, Volume: 31, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Venous Thromboembolism	2018
Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy. Molecular cancer therapeutics, 2017, Volume: 16, Issue:11 Topics: Aminopyridines; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Endothelial Cells; Humans; Imidazoles; Mice; Morpholines; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Neoplasms; Neovascularization, Pathologic; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Photochemotherapy; Porphyrins; Protein Kinase Inhibitors; Quinolines; Signal Transduction; Thiazoles; Verteporfin; Xenograft Model Antitumor Assays	2017
Laser-responsive liposome for selective tumor targeting of nitazoxanide nanoparticles. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Jan-01, Volume: 111 Topics: Animals; Antiparasitic Agents; Lasers; Liposomes; Mice; Nanoparticles; Neoplasms; Nitro Compounds; Particle Size; Thiazoles	2018
Interdependence of GLO I and PKM2 in the Metabolic shift to escape apoptosis in GLO I-dependent cancer cells. Archives of biochemistry and biophysics, 2018, 01-15, Volume: 638 Topics: Apoptosis; Butyrates; Carrier Proteins; Cell Line, Tumor; Citric Acid Cycle; Drug Screening Assays, Antitumor; Humans; Lactoylglutathione Lyase; Membrane Proteins; Naphthoquinones; Neoplasm Proteins; Neoplasms; Pyruvate Kinase; Pyruvic Acid; Thiazoles; Thyroid Hormone-Binding Proteins; Thyroid Hormones	2018
Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer. The New England journal of medicine, 2018, 02-15, Volume: 378, Issue:7 Topics: Administration, Oral; Anticoagulants; Factor Xa Inhibitors; Humans; Neoplasms; Pyridines; Thiazoles; Treatment Outcome; Venous Thromboembolism	2018
MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent. Molecular imaging and biology, 2018, Volume: 20, Issue:4 Topics: Animals; Carbocyanines; Cell Line; Chitosan; Coloring Agents; Coumarins; Humans; Hyperthermia, Induced; Light; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Neoplasms; Paclitaxel; Phototherapy; Spectroscopy, Near-Infrared; Theranostic Nanomedicine; Thiazoles; Tissue Distribution	2018
The PI3Kα Inhibitor Alpelisib Has Activity in Cancer discovery, 2018, Volume: 8, Issue:4 Topics: Class I Phosphatidylinositol 3-Kinases; Humans; Mutation; Neoplasms; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Thiazoles	2018
Isoform-Selective Phosphatidylinositol 3-Kinase Inhibition in Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 05-01, Volume: 36, Issue:13 Topics: Class I Phosphatidylinositol 3-Kinases; Humans; Neoplasms; Phosphatidylinositol 3-Kinase; Protein Isoforms; Thiazoles	2018
Comparison of the effects of edoxaban, an oral direct factor Xa inhibitor, on venous thromboembolism between patients with and without cancer. Journal of cardiology, 2018, Volume: 72, Issue:2 Topics: Aged; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Neoplasms; Pulmonary Embolism; Pyridines; Recurrence; Retrospective Studies; Thiazoles; Venous Thromboembolism	2018
Oxazole and thiazole analogs of sulindac for cancer prevention. Future medicinal chemistry, 2018, 04-01, Volume: 10, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Design; Drug Screening Assays, Antitumor; Female; Heterografts; Humans; Male; Neoplasms; Oxazoles; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Sulindac; Thiazoles	2018
Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex. Nucleic acids research, 2018, 06-20, Volume: 46, Issue:11 Topics: A549 Cells; Apoptosis; Cell Line, Tumor; Cell Proliferation; Distamycins; Down-Regulation; G-Quadruplexes; Gene Expression; HeLa Cells; Humans; Models, Molecular; Neoplasms; Peptides; Proto-Oncogene Proteins c-myc; S Phase Cell Cycle Checkpoints; Structure-Activity Relationship; Thiazoles	2018
Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention. Gene, 2018, Sep-05, Volume: 670 Topics: Alternative Splicing; Cell Line, Tumor; Exons; Gene Expression Regulation; Harmine; HL-60 Cells; Homeostasis; Hot Temperature; Humans; Introns; Neoplasms; Osmotic Pressure; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Stress, Physiological; Thiazoles	2018
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types. Investigational new drugs, 2019, Volume: 37, Issue:2 Topics: Apoptosis; Cell Movement; Cell Proliferation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; MAP Kinase Signaling System; MCF-7 Cells; Mesalamine; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; raf Kinases; ras Proteins; Thiazoles; Tumor Cells, Cultured	2019
Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer. Mini reviews in medicinal chemistry, 2019, Volume: 19, Issue:5 Topics: Antineoplastic Agents; Arachidonic Acids; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Endocannabinoids; Enzyme Inhibitors; Female; Glycerides; Humans; Lung Neoplasms; Molecular Docking Simulation; Monoacylglycerol Lipases; Neoplasms; Structure-Activity Relationship; Thiazoles	2019
Edoxaban for Cancer-Associated Venous Thromboembolism. The New England journal of medicine, 2018, 07-05, Volume: 379, Issue:1 Topics: Administration, Oral; Anticoagulants; Factor Xa Inhibitors; Humans; Neoplasms; Pyridines; Thiazoles; Venous Thromboembolism	2018
Edoxaban for Cancer-Associated Venous Thromboembolism. The New England journal of medicine, 2018, 07-05, Volume: 379, Issue:1 Topics: Humans; Neoplasms; Pyridines; Thiazoles; Venous Thromboembolism	2018
Edoxaban for Cancer-Associated Venous Thromboembolism. The New England journal of medicine, 2018, 07-05, Volume: 379, Issue:1 Topics: Humans; Neoplasms; Pyridines; Thiazoles; Venous Thromboembolism	2018
Edoxaban for Cancer-Associated Venous Thromboembolism. The New England journal of medicine, 2018, 07-05, Volume: 379, Issue:1 Topics: Humans; Neoplasms; Pyridines; Thiazoles; Venous Thromboembolism	2018
Edoxaban for Cancer-Associated Venous Thromboembolism. The New England journal of medicine, 2018, 07-05, Volume: 379, Issue:1 Topics: Humans; Neoplasms; Pyridines; Thiazoles; Venous Thromboembolism	2018
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:9 Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Dalteparin; Factor Xa Inhibitors; Hemorrhage; Humans; Multicenter Studies as Topic; Neoplasms; Observational Studies as Topic; Patient Acceptance of Health Care; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2018
Benign Synthesis of Thiazolo-androstenone Derivatives as Potent Anticancer Agents. Organic letters, 2018, 09-21, Volume: 20, Issue:18 Topics: Androstenes; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Density Functional Theory; Drug Screening Assays, Antitumor; Humans; Neoplasms; Structure-Activity Relationship; Thiazoles	2018
The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen. PloS one, 2018, Volume: 13, Issue:9 Topics: Antineoplastic Agents; Cathepsin B; Cell Adhesion; Cell Line, Tumor; Cell Movement; Collagen; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Extracellular Space; Human Umbilical Vein Endothelial Cells; Humans; Integrin beta1; Macrolides; Neoplasms; Thiazoles; Vacuolar Proton-Translocating ATPases	2018
[Treatment of cancer-associated venous thromboembolism]. Giornale italiano di cardiologia (2006), 2018, Volume: 19, Issue:9 Suppl 1 Topics: Anticoagulants; Dalteparin; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Practice Guidelines as Topic; Pyridines; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism	2018
[Edoxaban in patients with atrial fibrillation and cancer]. Giornale italiano di cardiologia (2006), 2018, Volume: 19, Issue:9 Suppl 1 Topics: Anticoagulants; Atrial Fibrillation; Cancer Survivors; Cardiovascular Diseases; Embolism; Factor Xa Inhibitors; Hemorrhage; Humans; International Normalized Ratio; Neoplasms; Pyridines; Stroke; Thiazoles; Warfarin	2018
Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer and/or older age. Heart and vessels, 2019, Volume: 34, Issue:4 Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Japan; Lower Extremity; Male; Middle Aged; Neoplasms; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism	2019
Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy. Bioorganic & medicinal chemistry letters, 2018, 12-15, Volume: 28, Issue:23-24 Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Drug Design; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 8; Matrix Metalloproteinase Inhibitors; Molecular Docking Simulation; Neoplasms; Pyrazoles; Quantitative Structure-Activity Relationship; Thiazoles	2018
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial. Journal of the American Heart Association, 2018, 08-21, Volume: 7, Issue:16 Topics: Aged; Anticoagulants; Atrial Fibrillation; Comorbidity; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Neoplasms; Hemorrhage; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prostatic Neoplasms; Pyridines; Stroke; Thiazoles; Warfarin	2018
Lakartidningen, 2018, 12-04, Volume: 115 Topics: Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasms; Perioperative Care; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2018
MDM2 inhibitor ameliorates cisplatin-induced nephropathy via NFκΒ signal inhibition. Pharmacology research & perspectives, 2019, Volume: 7, Issue:1 Topics: Acute Kidney Injury; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion Molecules; Cisplatin; Disease Models, Animal; HEK293 Cells; Humans; Imidazoles; Kidney Tubules; Male; Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Treatment Outcome	2019
Synthesis, Characterization, and Biological Activity of a Novel Series of Benzo[4,5]imidazo[2,1- Molecules (Basel, Switzerland), 2019, Feb-14, Volume: 24, Issue:4 Topics: Acetamides; Antineoplastic Agents; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Molecular Docking Simulation; Neoplasms; Thiazoles	2019
[Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Volume: 139, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Cohort Studies; Female; Hemorrhage; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Severity of Illness Index; Thiazoles; Venous Thromboembolism	2019
ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway. Cancer letters, 2019, 07-10, Volume: 454 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; HCT116 Cells; HeLa Cells; Histone Demethylases; Humans; Hydrazines; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Morpholines; Neoplasms; S Phase; Signal Transduction; Sulfones; Thiazoles; TOR Serine-Threonine Kinases; Transcription Factors; Up-Regulation; Xenograft Model Antitumor Assays	2019
Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA Platination. Inorganic chemistry, 2019, May-06, Volume: 58, Issue:9 Topics: Antineoplastic Agents; Cisplatin; DNA; DNA Adducts; Histones; Humans; Neoplasms; Organoplatinum Compounds; Thiazoles	2019
5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors. European journal of medicinal chemistry, 2019, Aug-01, Volume: 175 Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Humans; Neoplasms; Spectrum Analysis; Structure-Activity Relationship; Thiazoles	2019
Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosis. Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:3 Topics: Anticoagulants; Cost-Benefit Analysis; Dalteparin; Gastrointestinal Neoplasms; Humans; Markov Chains; Models, Theoretical; Neoplasms; Pyridines; Quality-Adjusted Life Years; Thiazoles; Thrombosis; United States	2019
Discovery of a novel DNA binding agent via design and synthesis of new thiazole hybrids and fused 1,2,4-triazines as potential antitumor agents: Computational, spectrometric and in silico studies. Bioorganic chemistry, 2019, Volume: 90 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; DNA; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Thiazoles; Triazines; Tumor Cells, Cultured	2019
VTE and anti-coagulation therapy in cancer patients. European heart journal. Cardiovascular pharmacotherapy, 2019, 10-01, Volume: 5, Issue:4 Topics: Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Dalteparin; Factor Xa Inhibitors; Humans; Neoplasms; Pyridines; Recurrence; Risk Factors; Secondary Prevention; Thiazoles; Treatment Outcome; Venous Thromboembolism	2019
Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. The Journal of biological chemistry, 2013, Mar-29, Volume: 288, Issue:13 Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Epigenesis, Genetic; High-Throughput Screening Assays; Histone Demethylases; Histones; Humans; Insecta; Jumonji Domain-Containing Histone Demethylases; Neoplasms; Nuclear Proteins; Peptides; Protein Binding; Recombinant Proteins; Repressor Proteins; Thiazoles	2013
Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging. Journal of the American Chemical Society, 2013, May-01, Volume: 135, Issue:17 Topics: Antineoplastic Agents; Cell Survival; Chemoradiotherapy; Cisplatin; Coloring Agents; Contrast Media; Drug Delivery Systems; Gadolinium; HeLa Cells; Humans; Light; Luminescence; Magnetic Resonance Imaging; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Neoplasms; Particle Size; Porosity; Scattering, Radiation; Tetrazolium Salts; Thiazoles	2013
Homopiperazine derivatives as a novel class of proteasome inhibitors with a unique mode of proteasome binding. PloS one, 2013, Volume: 8, Issue:4 Topics: Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Drug Discovery; Humans; Immunoblotting; Neoplasms; Piperazines; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Tetrazolium Salts; Thiazoles	2013
Analyses of the combination of 6-MP and dasatinib in cell culture. International journal of oncology, 2013, Volume: 43, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Dasatinib; Drug Synergism; Humans; In Vitro Techniques; MCF-7 Cells; Mercaptopurine; Neoplasms; Pyrimidines; Thiazoles; Tumor Stem Cell Assay	2013
Uniform magnesium silicate hollow spheres as high drug-loading nanocarriers for cancer therapy with low systemic toxicity. Dalton transactions (Cambridge, England : 2003), 2013, Jun-28, Volume: 42, Issue:24 Topics: Animals; Antineoplastic Agents; Drug Carriers; Endocytosis; Female; Fluorescein-5-isothiocyanate; Hemolysis; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Lysosomes; Magnesium Silicates; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Nanoparticles; Neoplasm Transplantation; Neoplasms; Particle Size; Tetrazolium Salts; Thiazoles	2013
Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer. Cancer discovery, 2013, Volume: 3, Issue:9 Topics: Animals; Cell Line, Tumor; Dasatinib; ErbB Receptors; Gefitinib; Heterografts; High-Throughput Screening Assays; Humans; MAP Kinase Signaling System; Mice; Neoplasm Transplantation; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Receptor, Fibroblast Growth Factor, Type 3; RNA Interference; RNA, Small Interfering; Signal Transduction; Thiazoles	2013
Multi-shell structured fluorescent-magnetic nanoprobe for target cell imaging and on-chip sorting. ACS applied materials & interfaces, 2013, Aug-14, Volume: 5, Issue:15 Topics: Cell Line, Tumor; Cell Separation; Cell Survival; Fluorescent Dyes; HeLa Cells; HL-60 Cells; Humans; Indoles; K562 Cells; Magnetics; Microfluidics; Nanostructures; Neoplasms; Polyethylene Glycols; Polymers; Quantum Dots; Tetrazolium Salts; Thiazoles	2013
Aptamer-directed synthesis of multifunctional lanthanide-doped porous nanoprobes for targeted imaging and drug delivery. Small (Weinheim an der Bergstrasse, Germany), 2013, Dec-20, Volume: 9, Issue:24 Topics: Cell Line; Cell Line, Tumor; Contrast Media; DNA; Drug Delivery Systems; Humans; Lanthanoid Series Elements; MCF-7 Cells; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Nanotechnology; Neoplasms; Oligonucleotides; Porosity; Spectroscopy, Fourier Transform Infrared; Tetrazolium Salts; Thiazoles	2013
[A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:8 Topics: Antiemetics; Basal Ganglia Diseases; Female; Humans; Isoindoles; Male; Middle Aged; Nausea; Neoplasms; Opioid-Related Disorders; Palliative Care; Prochlorperazine; Retrospective Studies; Thiazoles; Vomiting	2013
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs. Bioorganic & medicinal chemistry letters, 2013, Nov-01, Volume: 23, Issue:21 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Depsipeptides; Histone Deacetylase Inhibitors; Humans; Molecular Docking Simulation; Neoplasms; Oxazoles; Thiazoles	2013
Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines. Molecular cancer therapeutics, 2013, Volume: 12, Issue:11 Topics: Aniline Compounds; Animals; Antineoplastic Agents; Benzothiazoles; Binding Sites; Butadienes; Cell Line; Cell Proliferation; DNA-Binding Proteins; Fluorescent Dyes; HEK293 Cells; HSC70 Heat-Shock Proteins; Humans; Indoles; MCF-7 Cells; Mice; Molecular Docking Simulation; Neoplasms; NIH 3T3 Cells; Nitriles; Protein Binding; Proto-Oncogene Proteins B-raf; Sulfonamides; Thiazoles; Transcription Factors; Vemurafenib	2013
A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance. Cancer research, 2013, Nov-01, Volume: 73, Issue:21 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Cycle; Cell Proliferation; Chromatography, High Pressure Liquid; Computer Simulation; Deoxycytidine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Flow Cytometry; Gemcitabine; Half-Life; Humans; Hydroxyurea; Interleukin-2 Receptor alpha Subunit; Mice; Mice, Inbred NOD; Mice, SCID; Mutagenesis, Site-Directed; Mutation; Neoplasms; Protein Conformation; Ribonucleotide Reductases; Small Molecule Libraries; Structure-Activity Relationship; Surface Plasmon Resonance; Tandem Mass Spectrometry; Thiazoles	2013
V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo. International journal of cancer, 2014, May-15, Volume: 134, Issue:10 Topics: Animals; Blotting, Western; Cathepsin B; Cell Line, Tumor; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Lysosomes; Macrolides; MCF-7 Cells; Mice; Mice, Inbred BALB C; Neoplasms; Neoplasms, Experimental; Protein Transport; Receptor, IGF Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Thiazoles; Tumor Burden; Vacuolar Proton-Translocating ATPases	2014
Photoswitchable nanoparticles for in vivo cancer chemotherapy. Proceedings of the National Academy of Sciences of the United States of America, 2013, Nov-19, Volume: 110, Issue:47 Topics: Antineoplastic Agents; Benzopyrans; Drug Delivery Systems; HeLa Cells; Humans; Indoles; Nanoparticles; Neoplasms; Nitro Compounds; Tetrazolium Salts; Thiazoles; Time Factors; Ultraviolet Rays	2013
Studies on the synthetic and structural aspects of benzosuberones bearing 2, 4-thiazolidenone moiety as potential anti-cancer agents. European journal of medicinal chemistry, 2014, Volume: 71 Topics: Antineoplastic Agents; Cell Line, Tumor; Cycloheptanes; HEK293 Cells; HeLa Cells; Humans; Models, Molecular; Neoplasms; Thiazoles	2014
Palladium nanosheets as highly stable and effective contrast agents for in vivo photoacoustic molecular imaging. Nanoscale, 2014, Volume: 6, Issue:3 Topics: Acoustics; Animals; Cell Line, Tumor; Cell Survival; Contrast Media; Gold; Metal Nanoparticles; Mice; Nanostructures; Neoplasm Transplantation; Neoplasms; Optics and Photonics; Palladium; Perfusion; Photochemistry; Tetrazolium Salts; Thiazoles; Tissue Distribution; Tomography; Transducers	2014
Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proceedings of the National Academy of Sciences of the United States of America, 2014, Feb-25, Volume: 111, Issue:8 Topics: Animals; Blotting, Western; Caveolae; Cell Line; Chemical Engineering; Drug Delivery Systems; Electrolytes; Endothelial Cells; Flow Cytometry; Fluorescent Antibody Technique; Humans; Mice; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Polymers; Real-Time Polymerase Chain Reaction; Static Electricity; Sulfonic Acids; Tetrazolium Salts; Thiazoles	2014
Synthesis, in vitro anticancer evaluation and in silico studies of novel imidazo[2,1-b]thiazole derivatives bearing pyrazole moieties. European journal of medicinal chemistry, 2014, Mar-21, Volume: 75 Topics: Antineoplastic Agents; Cell Line, Tumor; Computer Simulation; Drug Design; Drug Screening Assays, Antitumor; Humans; Imidazoles; Neoplasms; Pyrazoles; Thiazoles	2014
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials. Molecular cancer therapeutics, 2014, Volume: 13, Issue:5 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Mice; Mutation; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; PTEN Phosphohydrolase; Rats; Thiazoles; Xenograft Model Antitumor Assays	2014
P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Female; Gene Fusion; Histone Deacetylase Inhibitors; Humans; Indicators and Reagents; Luciferases; Luminescence; Mice; Mice, Nude; Microscopy, Confocal; Molecular Imaging; Neoplasms; Plasmids; Positron-Emission Tomography; Tetrazolium Salts; Thiazoles; Transcription, Genetic; Transfection	2014
Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. Oncogene, 2015, Mar-05, Volume: 34, Issue:10 Topics: Animals; Benzamides; Binding Sites; Cell Line, Tumor; Cytoskeletal Proteins; Disease Models, Animal; Disease Progression; Gene Expression; Heterografts; Humans; Indoles; Inhibitory Concentration 50; Mitosis; Models, Molecular; Molecular Conformation; Neoplasms; NIMA-Related Kinases; Nuclear Proteins; Phosphorylation; Prognosis; Protein Binding; Protein Serine-Threonine Kinases; Proteolysis; Thiazoles; Valerates	2015
Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents. Bioorganic & medicinal chemistry letters, 2014, May-15, Volume: 24, Issue:10 Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Humans; Models, Molecular; Naphthalenes; Neoplasms; Pyrazoles; Structure-Activity Relationship; Thiazoles	2014
Modulator effects of meloxicam against doxorubicin-induced nephrotoxicity in mice. Journal of biochemical and molecular toxicology, 2014, Volume: 28, Issue:8 Topics: Animals; Caspase 3; Dinoprostone; Doxorubicin; Humans; Interleukin-6; Lipid Peroxidation; Male; Meloxicam; Mice; Neoplasms; Oxidative Stress; Renal Insufficiency; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha	2014
Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors. SAR and QSAR in environmental research, 2014, Volume: 25, Issue:8 Topics: Antineoplastic Agents; Checkpoint Kinase 1; Computer Simulation; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Quantitative Structure-Activity Relationship; Thiazoles	2014
B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL). Leukemia, 2014, Volume: 28, Issue:10 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dasatinib; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Neoplasm Transplantation; Neoplasms; Phosphorylation; Pyrimidines; src-Family Kinases; Thiazoles	2014
Suppression of tumor growth by Pleurotus ferulae ethanol extract through induction of cell apoptosis, and inhibition of cell proliferation and migration. PloS one, 2014, Volume: 9, Issue:7 Topics: Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Complex Mixtures; DNA Primers; Ethanol; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Medicine, Chinese Traditional; Mice; Neoplasm Invasiveness; Neoplasms; Pleurotus; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles	2014
Targeting inhibitor of apoptosis proteins for cancer therapy: a double-edge sword? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-01, Volume: 32, Issue:28 Topics: Antineoplastic Agents; Female; Humans; Inhibitor of Apoptosis Proteins; Male; Neoplasms; Thiazoles	2014
In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential. Oncotarget, 2014, Oct-15, Volume: 5, Issue:19 Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Cell Proliferation; HEK293 Cells; Humans; Luciferases, Renilla; Neoplasms; Oxadiazoles; Protein Binding; Protein Multimerization; Proto-Oncogene Proteins c-myc; Pyridines; Repressor Proteins; Thiazoles	2014
Ligand-based pharmacophore modeling, atom-based 3D-QSAR and molecular docking studies on substituted thiazoles and thiophenes as polo-like kinase 1 (Plk1) inhibitors. Combinatorial chemistry & high throughput screening, 2014, Volume: 17, Issue:10 Topics: Antineoplastic Agents; Cell Cycle Proteins; Drug Design; Humans; Molecular Docking Simulation; Neoplasms; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Quantitative Structure-Activity Relationship; Thiazoles; Thiophenes	2014
Synthesis and anticancer evaluation of 3-aryl-6-phenylimidazo [2,1-b]thiazoles. Bioorganic & medicinal chemistry letters, 2014, Dec-01, Volume: 24, Issue:23 Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Neoplasms; Thiazoles	2014
Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents. Bioorganic chemistry, 2014, Volume: 57 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclooxygenase Inhibitors; Drug Design; Humans; Molecular Docking Simulation; Neoplasms; Prostaglandin-Endoperoxide Synthases; Thiazoles	2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies. mAbs, 2014, Volume: 6, Issue:5 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody-Dependent Cell Cytotoxicity; Antigens, CD20; Blotting, Western; Cell Line, Tumor; Dasatinib; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; K562 Cells; Killer Cells, Natural; Mice, Inbred C57BL; Neoplasms; Oligonucleotide Array Sequence Analysis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Rituximab; Signal Transduction; src-Family Kinases; Thiazoles; Transcriptome	2014
Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy. Biomaterials, 2015, Volume: 42 Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Movement; Cell Survival; Collagen; Coumarins; Drug Combinations; Drug Delivery Systems; Endocytosis; Female; Human Umbilical Vein Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Laminin; Membrane Proteins; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Nanomedicine; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Paclitaxel; Peptides; Proteoglycans; Rats, Sprague-Dawley; Subcutaneous Tissue; Thiazoles; Xenograft Model Antitumor Assays	2015
Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ. Cancer cell, 2015, Jan-12, Volume: 27, Issue:1 Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Chromones; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Transplantation; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Signal Transduction; Thiazoles	2015
Biodegradable polymeric micelles encapsulated JK184 suppress tumor growth through inhibiting Hedgehog signaling pathway. Nanoscale, 2015, Feb-14, Volume: 7, Issue:6 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biocompatible Materials; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromatography, High Pressure Liquid; Drug Delivery Systems; Female; Hedgehog Proteins; Heterocyclic Compounds, 2-Ring; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Nude; Micelles; Nanomedicine; Neoplasm Transplantation; Neoplasms; Polymers; Signal Transduction; Thiazoles; Transgenes; Zebrafish	2015
Breaking up is hard to do: PI3K isoforms on the rebound. Cancer cell, 2015, Jan-12, Volume: 27, Issue:1 Topics: Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromones; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Neoplasms; ortho-Aminobenzoates; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Pyrimidinones; Thiazoles	2015
Chemical synthesis of a polypeptide backbone derived from the primary sequence of the cancer protein NY-ESO-1 enabled by kinetically controlled ligation and pseudoprolines. Biopolymers, 2015, Volume: 104, Issue:2 Topics: Antigens, Neoplasm; Membrane Proteins; Neoplasms; Peptides; Proline; Thiazoles	2015
Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting. PloS one, 2015, Volume: 10, Issue:2 Topics: Animals; Apoptosis; Binding Sites; Cell Line, Tumor; Cell Movement; Cell Proliferation; CSK Tyrosine-Protein Kinase; Dasatinib; Drug Design; ErbB Receptors; Female; Gefitinib; Humans; Mice; Mice, Inbred BALB C; Molecular Dynamics Simulation; Neoplasms; NIH 3T3 Cells; Phosphorylation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Quinazolines; src-Family Kinases; Thiazoles; Transplantation, Heterologous	2015
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer. Internal and emergency medicine, 2015, Volume: 10, Issue:6 Topics: Anticoagulants; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism	2015
3-[4-(1H-indol-3-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines, nortopsentin analogues with antiproliferative activity. Marine drugs, 2015, Apr-03, Volume: 13, Issue:4 Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Design; G2 Phase; Halogenation; Humans; Imidazoles; Indoles; Membrane Potential, Mitochondrial; Methylation; Mitochondria; Molecular Structure; Neoplasms; Pyridines; Pyrroles; Resting Phase, Cell Cycle; Thiazoles	2015
Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity. Molecules (Basel, Switzerland), 2015, Jun-23, Volume: 20, Issue:6 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Humans; Neoplasms; Pyrans; Structure-Activity Relationship; Thiazoles	2015
Discovery of a novel tricyclic 4H-thiazolo[5',4':4,5]pyrano[2,3-c]pyridine-2-amino scaffold and its application in a PI3Kα inhibitor with high PI3K isoform selectivity and potent cellular activity. Bioorganic & medicinal chemistry letters, 2015, Sep-01, Volume: 25, Issue:17 Topics: Amination; Animals; Class I Phosphatidylinositol 3-Kinases; Humans; Models, Molecular; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyridines; Rats; Thiazoles	2015
Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & medicinal chemistry letters, 2015, Sep-01, Volume: 25, Issue:17 Topics: Animals; Caco-2 Cells; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Mice, Nude; Models, Molecular; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship; Thiazoles	2015
Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Scientific reports, 2015, Aug-21, Volume: 5 Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Centrosome; Chromosomal Instability; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mitosis; Neoplasms; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Spindle Apparatus; Thiazoles; Urea	2015
Perospirone Exhibits Antiemetic Efficacy against Opioid-Induced Nausea in Patients with Advanced Cancer. Journal of palliative medicine, 2015, Volume: 18, Issue:10 Topics: Analgesics, Opioid; Antiemetics; Antipsychotic Agents; Female; Humans; Isoindoles; Japan; Male; Nausea; Neoplasms; Pain; Retrospective Studies; Thiazoles	2015
Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes. Journal of medicinal chemistry, 2015, Nov-12, Volume: 58, Issue:21 Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cymenes; Female; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Monoterpenes; Neoplasms; Ovarian Neoplasms; Ruthenium; Thiazoles; Transcriptome	2015
A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation. Oncotarget, 2015, Dec-08, Volume: 6, Issue:39 Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fibroblasts; HeLa Cells; HT29 Cells; Humans; Jurkat Cells; Membrane Proteins; Mice; Mitochondria; Neoplasms; Prohibitins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Repressor Proteins; Signal Transduction; Thiazoles; Time Factors; Transfection; Tumor Cells, Cultured; Up-Regulation	2015
HER2 missense mutations have distinct effects on oncogenic signaling and migration. Proceedings of the National Academy of Sciences of the United States of America, 2015, Nov-10, Volume: 112, Issue:45 Topics: Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colony-Forming Units Assay; Flow Cytometry; Gene Targeting; HEK293 Cells; Humans; Immunoblotting; Lapatinib; Mutation, Missense; Neoplasms; Quinazolines; Quinolines; Receptor, ErbB-2; Signal Transduction; Thiazoles	2015
Design, synthesis and biological evaluation of bisthiazole-based trifluoromethyl ketone derivatives as potent HDAC inhibitors with improved cellular efficacy. European journal of medicinal chemistry, 2016, Apr-13, Volume: 112 Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Halogenation; Histone Deacetylase Inhibitors; Humans; Ketones; Methylation; Neoplasms; Structure-Activity Relationship; Thiazoles; Zinc	2016
Determination of Cytotoxicity. Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 2016, Volume: 71 Topics: Animals; Antineoplastic Agents, Phytogenic; Bioprospecting; Cell Survival; Colorimetry; Coloring Agents; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Microscopy; Neoplasms; Phytochemicals; Phytotherapy; Plant Extracts; Plants, Medicinal; Tetrazolium Salts; Thiazoles; Trypan Blue	2016
Design and synthesis of novel 5-aminosalicylate (5-ASA)-4-thiazolinone hybrid derivatives with promising antiproliferative activity. Bioorganic & medicinal chemistry letters, 2016, Apr-01, Volume: 26, Issue:7 Topics: Antineoplastic Agents; Cell Proliferation; Humans; MCF-7 Cells; Mesalamine; Models, Molecular; Neoplasms; Structure-Activity Relationship; Thiazoles	2016
A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells. Oncotarget, 2016, Jun-14, Volume: 7, Issue:24 Topics: Cell Line; Cell Line, Tumor; Cellular Senescence; Gene Expression Regulation, Neoplastic; HEK293 Cells; Heterocyclic Compounds, 2-Ring; Humans; MCF-7 Cells; MicroRNAs; Neoplasms; Neoplastic Stem Cells; Polycomb Repressive Complex 1; Promoter Regions, Genetic; Protein Binding; Thiazoles	2016
MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition. Molecular oncology, 2016, Volume: 10, Issue:7 Topics: Adenosine Triphosphatases; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Female; Glycolysis; Humans; Imidazoles; Insulin-Like Growth Factor Binding Protein 3; Mice, Inbred BALB C; Mice, SCID; Neoplasms; Piperazines; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Thiazoles; Tumor Suppressor Protein p53	2016
Fatostatin Inhibits Cancer Cell Proliferation by Affecting Mitotic Microtubule Spindle Assembly and Cell Division. The Journal of biological chemistry, 2016, 08-12, Volume: 291, Issue:33 Topics: Cell Division; G2 Phase; HeLa Cells; Humans; Neoplasm Proteins; Neoplasms; Pyridines; Spindle Apparatus; Sterol Regulatory Element Binding Proteins; Thiazoles	2016
Direct oral anticoagulants and cancer: no swansong yet for the low-molecular-weight heparins. The Lancet. Haematology, 2016, Volume: 3, Issue:8 Topics: Anticoagulants; Double-Blind Method; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Pyridines; Thiazoles; Venous Thromboembolism	2016
Discovery and Optimization of N-Substituted 2-(4-pyridinyl)thiazole carboxamides against Tumor Growth through Regulating Angiogenesis Signaling Pathways. Scientific reports, 2016, 09-16, Volume: 6 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chick Embryo; Colony-Forming Units Assay; Drug Design; Drug Discovery; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Piperidines; Quinazolines; Rats, Sprague-Dawley; Signal Transduction; Stress Fibers; Thiazoles; Wound Healing	2016
Targeting Cancer Cells with a Bisphosphonate Prodrug. ChemMedChem, 2016, 12-16, Volume: 11, Issue:24 Topics: Animals; Antineoplastic Agents; Biological Assay; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Disease Models, Animal; Drug Delivery Systems; Humans; Inhibitory Concentration 50; Mice; Molecular Structure; Neoplasms; Prodrugs; Thiazoles	2016
Facile synthesis of novel substituted aryl-thiazole (SAT) analogs via one-pot multi-component reaction as potent cytotoxic agents against cancer cell lines. Bioorganic chemistry, 2017, Volume: 70 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combinatorial Chemistry Techniques; Drug Design; Drug Screening Assays, Antitumor; HCT116 Cells; HeLa Cells; Humans; MCF-7 Cells; Neoplasms; Structure-Activity Relationship; Thiazoles	2017
Relevance of mortalin to cancer cell stemness and cancer therapy. Scientific reports, 2017, 02-06, Volume: 7 Topics: Antineoplastic Agents; Biomarkers, Tumor; Caffeic Acids; Cell Line; Cell Line, Tumor; HSP70 Heat-Shock Proteins; Humans; Neoplasms; Neoplastic Stem Cells; Phenylethyl Alcohol; Pyridines; RNA, Small Interfering; Thiazoles; Up-Regulation	2017
Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1. Scientific reports, 2017, 02-09, Volume: 7 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; Heterografts; Humans; Mice; Neoplasm Transplantation; Neoplasms; Paclitaxel; Peptidomimetics; Thiazoles; Treatment Outcome; Valine	2017
Disease progression in some cancers may be due to low blood levels of targeted therapies. Journal of the National Cancer Institute, 2008, Jul-02, Volume: 100, Issue:13 Topics: Administration, Oral; Antineoplastic Agents; Benzamides; Biological Availability; Dasatinib; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Patient Compliance; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles	2008
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer. Bioorganic & medicinal chemistry letters, 2008, Sep-01, Volume: 18, Issue:17 Topics: 3T3 Cells; Amides; Animals; Antineoplastic Agents; Female; Humans; Mice; Mice, Nude; Neoplasms; Rats; Receptor, Macrophage Colony-Stimulating Factor; Thiazoles	2008
Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Immunohistochemistry; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Naphthyridines; Neoplasms; Thiazoles; Xenograft Model Antitumor Assays	2009
Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. European journal of medicinal chemistry, 2009, Volume: 44, Issue:4 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Neoplasms; Pyrazoles; Thiazoles	2009
Screen anticancer drug in vitro using resonance light scattering technique. Talanta, 2009, Feb-15, Volume: 77, Issue:4 Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Colorimetry; Drug Screening Assays, Antitumor; Formazans; Humans; Inhibitory Concentration 50; Light; Mice; Neoplasms; Scattering, Radiation; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles; Time Factors	2009
Japonicones A-D, bioactive dimeric sesquiterpenes from Inula japonica Thunb. Bioorganic & medicinal chemistry letters, 2009, Feb-01, Volume: 19, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Crystallography, X-Ray; Dimerization; Humans; Inula; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Conformation; Molecular Structure; Neoplasms; Plant Extracts; Sesquiterpenes; Sesquiterpenes, Eudesmane; Sesquiterpenes, Guaiane; Stereoisomerism; Tetrazolium Salts; Thiazoles	2009
Porphyrins containing nitric oxide donors: Synthesis and cancer cell-oriented NO release. Bioorganic & medicinal chemistry letters, 2009, Mar-15, Volume: 19, Issue:6 Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Neoplasms; Nitric Oxide; Nitric Oxide Donors; Porphyrins; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Thiazoles	2009
The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo. Cancer biotherapy & radiopharmaceuticals, 2009, Volume: 24, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunotherapy; Killer Cells, Natural; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Taxoids; Tetrazolium Salts; Thiazoles	2009
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials, 2009, Volume: 30, Issue:19 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antioxidants; Bentonite; Cell Line; Coumarins; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Therapy; Humans; Lactic Acid; Male; Nanoparticles; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Taxoids; Thiazoles; Vitamin E	2009
Conjugation with alpha-linolenic acid improves cancer cell uptake and cytotoxicity of doxorubicin. Bioorganic & medicinal chemistry letters, 2009, May-01, Volume: 19, Issue:9 Topics: alpha-Linolenic Acid; Cell Line, Tumor; Chemistry, Pharmaceutical; Chromatography, Liquid; Doxorubicin; Drug Design; Endocytosis; Flow Cytometry; Humans; Inhibitory Concentration 50; Microscopy, Fluorescence; Models, Chemical; Neoplasms; Spectrometry, Mass, Electrospray Ionization; Tetrazolium Salts; Thiazoles	2009
The Na+/K+-ATPase is the Achilles heel of multi-drug-resistant cancer cells. Cancer letters, 2009, Sep-08, Volume: 282, Issue:1 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cardenolides; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; HeLa Cells; Humans; Hydroxyurea; Ligands; Neoplasms; Sodium-Potassium-Exchanging ATPase; Thiazoles	2009
Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. Molecular cancer therapeutics, 2009, Volume: 8, Issue:5 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Humans; Macrolides; Mice; Mice, Nude; Mice, SCID; Neoplasms; Thiazoles; Xenograft Model Antitumor Assays	2009
Inhibitory effects of chitooligosaccharides on tumor growth and metastasis. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2009, Volume: 47, Issue:8 Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Chitosan; Coloring Agents; Gelatin; Humans; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, SCID; Molecular Weight; Neoplasm Metastasis; Neoplasms; Oligosaccharides; Tetrazolium Salts; Thiazoles	2009
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009, Jul-15, Volume: 877, Issue:22 Topics: Antineoplastic Agents; Benzamides; Benzenesulfonates; Chromatography, Liquid; Dasatinib; Drug Monitoring; Humans; Imatinib Mesylate; Indoles; Lapatinib; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Tandem Mass Spectrometry; Thiazoles	2009
Design, synthesis and biological evaluation of 2H-benzo[b][1,4] oxazine derivatives as hypoxia targeted compounds for cancer therapeutics. Bioorganic & medicinal chemistry letters, 2009, Aug-01, Volume: 19, Issue:15 Topics: Antineoplastic Agents; Benzoxazines; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitory Concentration 50; Models, Chemical; Neoplasms; Oxazines; Polymerase Chain Reaction; Positron-Emission Tomography; Tetrazolium Salts; Thiazoles; Tomography, Emission-Computed, Single-Photon; Vascular Endothelial Growth Factor A	2009
Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. The Journal of biological chemistry, 2009, Aug-28, Volume: 284, Issue:35 Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; ERRalpha Estrogen-Related Receptor; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasms; Nitriles; Receptors, Estrogen; Thiazoles	2009
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Caspase 3; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; HCT116 Cells; HeLa Cells; Histones; HT29 Cells; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Molecular Structure; Neoplasms; Phenylurea Compounds; Phosphorylation; Protein Serine-Threonine Kinases; Thiazoles; Tumor Burden; Xenograft Model Antitumor Assays	2010
Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties. British journal of pharmacology, 2009, Volume: 158, Issue:4 Topics: Aniline Compounds; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cyclosporins; Dasatinib; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Fusion Proteins, bcr-abl; Humans; Indoles; K562 Cells; Neoplasm Proteins; Neoplasms; Nitriles; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinolines; Substrate Specificity; Thiazoles	2009
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10). PloS one, 2009, Oct-20, Volume: 4, Issue:10 Topics: Antineoplastic Agents; Benzamides; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Models, Chemical; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Piperazines; Pyrimidines; Tetrazolium Salts; Thiazoles	2009
Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid. Technology in cancer research & treatment, 2009, Volume: 8, Issue:6 Topics: Adsorption; Cell Line, Tumor; DNA; Drug Delivery Systems; Genetic Vectors; Humans; Lipids; Methacrylates; Mitochondria; Nanoparticles; Nanotechnology; Neoplasms; Plasmids; Polymers; Polymethacrylic Acids; Recombination, Genetic; Tetrazolium Salts; Thiazoles; Transfection	2009
Novel amidino substituted 2-phenylbenzothiazoles: synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo. Bioorganic & medicinal chemistry, 2010, Volume: 18, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Lethal Dose 50; Mice; Mice, Inbred BALB C; Neoplasms; Thiazoles	2010
Targeting the tumor microenvironment with SRC kinase inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Feb-01, Volume: 16, Issue:3 Topics: Animals; Dasatinib; Endothelial Cells; Fusion Proteins, bcr-abl; Male; Mice; Myeloid Cells; Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Stromal Cells; Thiazoles	2010
Enhancement of human cancer cell radiosensitivity by conjugated eicosapentaenoic acid - a mammalian DNA polymerase inhibitor. International journal of oncology, 2010, Volume: 36, Issue:3 Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Comet Assay; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Humans; Neoplasms; Nucleic Acid Synthesis Inhibitors; Tetrazolium Salts; Thiazoles; Treatment Outcome	2010
2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorganic & medicinal chemistry letters, 2010, Mar-01, Volume: 20, Issue:5 Topics: Animals; Antineoplastic Agents; Catalytic Domain; Crystallography, X-Ray; Cyclic AMP-Dependent Protein Kinases; Cyclin-Dependent Kinase 2; Isoquinolines; Mice; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Structure-Activity Relationship; Thiadiazoles; Thiazoles	2010
The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Coloring Agents; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Green Fluorescent Proteins; Humans; L-Lactate Dehydrogenase; Microscopy, Confocal; Necrosis; Neoplasms; Rhodamines; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53	2010
Cytotoxicity and utility of 1-indanone in the synthesis of some new heterocycles. Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:4 Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Heterocyclic Compounds; Humans; Hydrazones; Indans; Neoplasms; Thiazoles; Thiazolidines; Triazines	2010
New platinum-oxicam complexes as anti-cancer drugs. Synthesis, characterization, release studies from smart hydrogels, evaluation of reactivity with selected proteins and cytotoxic activity in vitro. Journal of inorganic biochemistry, 2010, Volume: 104, Issue:8 Topics: Antineoplastic Agents; Cell Proliferation; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Hydrogels; Meloxicam; Neoplasm Proteins; Neoplasms; Platinum; Thiazines; Thiazoles	2010
Anticancer effect and structure-activity analysis of marine products isolated from metabolites of mangrove fungi in the South China Sea. Marine drugs, 2010, Apr-01, Volume: 8, Issue:4 Topics: Antineoplastic Agents; Cell Line, Tumor; China; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fungi; Humans; Neoplasms; Rhizophoraceae; Seawater; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles	2010
Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells. Oncogene, 2010, Oct-14, Volume: 29, Issue:41 Topics: Blotting, Western; CDC2 Protein Kinase; Cell Line, Tumor; Cell Nucleus; Cyclin B1; DNA Damage; Down-Regulation; HCT116 Cells; HeLa Cells; Host-Pathogen Interactions; Human papillomavirus 16; Human papillomavirus 18; Humans; Mitosis; Neoplasms; Phosphorylation; Quinolines; RNA Interference; Serine; Thiazoles; Tumor Suppressor Protein p53	2010
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:3 Topics: Aged; Antineoplastic Agents; Benzamides; Benzenesulfonates; Blood Glucose; Dasatinib; Diabetes Mellitus; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Imatinib Mesylate; Indoles; Linear Models; Male; Middle Aged; Neoplasms; Niacinamide; Pennsylvania; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Sorafenib; Sunitinib; Thiazoles; Time Factors; Treatment Outcome	2011
Mo(II) complexes: a new family of cytotoxic agents? Journal of inorganic biochemistry, 2010, Volume: 104, Issue:11 Topics: 1-Octanol; Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Molybdenum; Neoplasms; Neuroblastoma; Nucleic Acid Conformation; Phenanthrolines; Tetrazolium Salts; Thiazoles; Water	2010
In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:3 Topics: Animal Structures; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blood Proteins; Cell Line, Tumor; Cell Survival; Doxorubicin; Feces; Female; Glucuronates; Glucuronidase; HL-60 Cells; Humans; Inhibitory Concentration 50; Liver; Mice; Mice, SCID; Neoplasms; Oxadiazoles; Plasma; Protein Binding; Protein Multimerization; Proto-Oncogene Proteins c-myc; Tandem Mass Spectrometry; Thiazoles; Treatment Outcome; Urine; Xenograft Model Antitumor Assays	2010
WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer research, 2010, Nov-15, Volume: 70, Issue:22 Topics: Autocrine Communication; beta Catenin; Blotting, Western; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; ERRalpha Estrogen-Related Receptor; Gene Expression Regulation, Neoplastic; HCT116 Cells; Heat-Shock Proteins; Humans; MSX1 Transcription Factor; Neoplasms; Nitriles; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Thiazoles; Transcription Factors; Transcriptional Activation; Wnt Proteins	2010
Protection of CHO cells by transfer of survivin driven by ovarian-specific promoter OSP-2. Molecular biology reports, 2011, Volume: 38, Issue:4 Topics: Analysis of Variance; Animals; Apoptosis; Apoptosis Regulatory Proteins; CHO Cells; Cricetinae; Cricetulus; Drug-Related Side Effects and Adverse Reactions; Flow Cytometry; Gene Targeting; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Neoplasms; Promoter Regions, Genetic; Survivin; Tetrazolium Salts; Thiazoles; Transfection	2011
Planar triazinium cations from VO(2+)-assisted ring cyclizations: a remarkably efficient thiazole species for nuclear staining, PDT and anaerobic photocleavage of DNA. Chemical communications (Cambridge, England), 2011, Apr-07, Volume: 47, Issue:13 Topics: Azo Compounds; Cations; Crystallography, X-Ray; Cyclization; DNA; HeLa Cells; Humans; Models, Molecular; Neoplasms; Photochemotherapy; Thiazoles; Triazines; Vanadium Compounds	2011
Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells. PloS one, 2011, Feb-18, Volume: 6, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; HCT116 Cells; Humans; Neoplasms; Pyrazines; Thiazoles; Thiostrepton	2011
Proteome interrogation using nanoprobes to identify targets of a cancer-killing molecule. Journal of the American Chemical Society, 2011, May-11, Volume: 133, Issue:18 Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Molecular Probes; Nanoparticles; Nanotechnology; Neoplasm Proteins; Neoplasms; Proteome; Structure-Activity Relationship; Thiazoles; Tubulin; Tubulin Modulators	2011
Layer-by-layer nanoparticles with a pH-sheddable layer for in vivo targeting of tumor hypoxia. ACS nano, 2011, Jun-28, Volume: 5, Issue:6 Topics: Animals; Cell Line, Tumor; Electrolytes; Female; HeLa Cells; Humans; Hydrogen-Ion Concentration; Hypoxia; Mice; Mice, Nude; Nanoparticles; Nanotechnology; Neoplasm Transplantation; Neoplasms; Particle Size; Polyethylene Glycols; Surface Properties; Tetrazolium Salts; Thiazoles	2011
Synthesis and antitumor activity of 3-(2-phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-phenyl-1,3-thiazol-4-yl)-1H-7-azaindoles. ChemMedChem, 2011, Jul-04, Volume: 6, Issue:7 Topics: Antineoplastic Agents; CDC2 Protein Kinase; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Indoles; Neoplasms; Protein Kinase Inhibitors; Thiazoles	2011
Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells. Virology journal, 2011, May-15, Volume: 8 Topics: Animals; Cell Cycle Proteins; Cell Line; Cell Survival; Female; G1 Phase; Hepatitis B virus; Hepatocytes; Humans; Mice; Mice, Nude; Neoplasms; Staining and Labeling; Stem Cells; Tetrazolium Salts; Thiazoles	2011
An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignancies. Anti-cancer drugs, 2011, Volume: 22, Issue:6 Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Benzimidazoles; Blotting, Western; Camptothecin; Caspases; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Child; Coloring Agents; Enzyme Activation; Enzyme Inhibitors; Humans; Neoplasms; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; RNA, Messenger; Tetrazolium Salts; Thiazoles; Thiophenes; Topoisomerase I Inhibitors	2011
Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. Colloids and surfaces. B, Biointerfaces, 2011, Oct-15, Volume: 87, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Coumarins; Desiccation; Drug Carriers; Emulsions; Fluorescent Dyes; Glutathione; Humans; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Oxidation-Reduction; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Thiazoles	2011
Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells. Molecular cancer therapeutics, 2011, Volume: 10, Issue:9 Topics: Acrylamides; Animals; Antimitotic Agents; Antineoplastic Agents; Apoptosis; Calcineurin Inhibitors; Cell Death; Cell Division; Cell Line, Tumor; Cytokinesis; Dynamins; Fibroblasts; HeLa Cells; HT29 Cells; Humans; Indoles; Mice; Neoplasms; Polyploidy; Protein Kinase Inhibitors; Quinolines; Thiazoles; Tubulin	2011
Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways. Journal of proteome research, 2011, Sep-02, Volume: 10, Issue:9 Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cluster Analysis; Computational Biology; Dasatinib; Databases, Protein; Humans; Intracellular Space; Models, Biological; Neoplasm Proteins; Neoplasms; Phosphotyrosine; Proteome; Pyrimidines; Signal Transduction; Thiazoles; Transforming Growth Factor beta	2011
Discovery of novel Thieno[2,3-d]pyrimidin-4-yl hydrazone-based cyclin-dependent kinase 4 inhibitors: synthesis, biological evaluation and structure-activity relationships. Chemical & pharmaceutical bulletin, 2011, Volume: 59, Issue:8 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Drug Screening Assays, Antitumor; Humans; Hydrazones; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Pyrimidines; Structure-Activity Relationship; Thiazoles	2011
Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Biomaterials, 2011, Volume: 32, Issue:35 Topics: Amino Acid Sequence; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Coumarins; Dioxanes; Drug Delivery Systems; Humans; Integrins; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Peptides; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Subcellular Fractions; Thiazoles	2011
Synthesis and activity of the archazolid western hemisphere. Organic & biomolecular chemistry, 2011, Oct-26, Volume: 9, Issue:22 Topics: Animals; Antineoplastic Agents; Arabidopsis; Biological Assay; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Macrolides; Neoplasms; Potoroidae; Thiazoles; Vacuolar Proton-Translocating ATPases; Vacuoles	2011
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agent. European journal of medicinal chemistry, 2011, Volume: 46, Issue:12 Topics: Animals; Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cell Proliferation; Female; G2 Phase; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Thiazoles; Tubulin; Tubulin Modulators	2011
New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies. European journal of medicinal chemistry, 2011, Volume: 46, Issue:12 Topics: Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Imidazoles; Melanoma; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Structure-Activity Relationship; Thiazoles	2011
Anti-proliferative activity and chemoprotective effects towards DNA oxidative damage of fresh and cooked Brassicaceae. The British journal of nutrition, 2012, Volume: 107, Issue:9 Topics: Anticarcinogenic Agents; Antioxidants; Brassica; Cell Proliferation; Comet Assay; Cooking; DNA Damage; HT29 Cells; Humans; Mutagens; Neoplasms; Nutritional Sciences; Oxidative Stress; Tetrazolium Salts; Thiazoles; Vegetables	2012
Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction. Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1 Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Cyanobacteria; Depsipeptides; Drug Design; Humans; Inhibitory Concentration 50; Isoleucine; Magnetic Resonance Spectroscopy; Models, Chemical; Neoplasms; Proto-Oncogene Proteins c-mdm2; Ribosomes; Thiazoles; Thiazolidines; Tumor Suppressor Protein p53	2012
Synthesis and in vitro and in vivo anticancer activity of novel phenylmethylene bis-isoxazolo[4,5-b]azepines. Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1 Topics: Animals; Antineoplastic Agents; Azepines; Cell Line, Tumor; Chemistry, Pharmaceutical; Cisplatin; Drug Design; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Inhibitory Concentration 50; Isoxazoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Methanol; Mice; Models, Chemical; Neoplasms; Spectrophotometry, Infrared; Tetrazolium Salts; Thiazoles	2012
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. PloS one, 2011, Volume: 6, Issue:12 Topics: Adipocytes; Adipogenesis; Antineoplastic Agents; Bone Marrow Cells; Cell Differentiation; Dasatinib; Humans; K562 Cells; Mesenchymal Stem Cells; Mesoderm; Neoplasms; Osteoblasts; Phenotype; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Stromal Cells; Thiazoles	2011
Nanoformulation of siRNA silencing Bcl-2 gene and its implication in cancer therapy. Arzneimittel-Forschung, 2011, Volume: 61, Issue:10 Topics: Animals; Blotting, Western; Cell Line, Tumor; Coloring Agents; Drug Compounding; Drug Delivery Systems; Electrochemistry; Female; Fluorescent Antibody Technique; Gene Silencing; Genes, bcl-2; Genetic Therapy; Humans; Lactic Acid; Male; Mice; Nanoparticles; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reverse Transcriptase Polymerase Chain Reaction; Rhodamines; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Transfection	2011
Macrophage immunomodulating and antitumor activities of polysaccharides isolated from Agaricus bisporus white button mushrooms. Journal of medicinal food, 2012, Volume: 15, Issue:1 Topics: Agaricus; Animals; Antineoplastic Agents; Biological Products; Cell Line, Tumor; Cell Proliferation; Female; Humans; Immunologic Factors; Immunomodulation; Inflammation Mediators; Macrophages; Male; Mice; Mice, Inbred C57BL; Molecular Weight; Neoplasms; NF-kappa B; Polysaccharides; Tetrazolium Salts; Thiazoles	2012
Facile synthesis of triterpenoid saponins bearing β-Glu/Gal-(1→3)-β-GluA methyl ester and their cytotoxic activities. Bioorganic & medicinal chemistry letters, 2012, Apr-01, Volume: 22, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Disaccharides; Flow Cytometry; Glycyrrhetinic Acid; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Neoplasms; Reactive Oxygen Species; Saponins; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Triterpenes; Ursolic Acid	2012
Gas-filled phospholipid nanoparticles conjugated with gadolinium play a role as a potential theragnostics for MR-guided HIFU ablation. PloS one, 2012, Volume: 7, Issue:3 Topics: Animals; Biocompatible Materials; Contrast Media; Gadolinium; Gadolinium DTPA; Gases; High-Intensity Focused Ultrasound Ablation; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Phantoms, Imaging; Phospholipids; Phosphorus; Tetrazolium Salts; Thiazoles; Treatment Outcome	2012
Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles. Journal of the American Chemical Society, 2012, May-09, Volume: 134, Issue:18 Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; Dasatinib; Delayed-Action Preparations; Deoxycytidine; Ethers; Gemcitabine; Humans; Nanoparticles; Neoplasms; Prodrugs; Pyrimidines; Silanes; Thiazoles	2012
Design, synthesis and antiproliferative activity of 2-acetamidothiazole-5-carboxamide derivatives. Medicinal chemistry (Shariqah (United Arab Emirates)), 2012, Volume: 8, Issue:4 Topics: Amides; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Dasatinib; Drug Design; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Molecular Structure; Neoplasms; Pyrimidines; Thiazoles	2012
Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance. PloS one, 2012, Volume: 7, Issue:4 Topics: Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Estrogen Receptor alpha; HEK293 Cells; HeLa Cells; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridinium Compounds; Tamoxifen; Thiazoles	2012
Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. Journal of controlled release : official journal of the Controlled Release Society, 2012, Oct-10, Volume: 163, Issue:1 Topics: Acoustics; Animals; Cell Line, Tumor; Coumarins; Cyanoacrylates; Drug Delivery Systems; Enbucrilate; Fluorescent Dyes; Mice; Microbubbles; Microscopy, Fluorescence; Neoplasms; Rhodamines; Thiazoles; Vascular Endothelial Growth Factor Receptor-2	2012
Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. The Journal of biological chemistry, 2012, Aug-10, Volume: 287, Issue:33 Topics: Amino Acid Substitution; Amyloid; Benzothiazoles; Humans; Mutation, Missense; Neoplasms; Prions; Protein Multimerization; Protein Structure, Quaternary; Protein Structure, Secondary; Thiazoles; Tumor Suppressor Protein p53; X-Ray Diffraction	2012
In vitro antioxidant and antiproliferative potential of medicinal plants used in traditional Indian medicine to treat cancer. Redox report : communications in free radical research, 2012, Volume: 17, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; India; Magnoliopsida; MCF-7 Cells; Medicine, East Asian Traditional; Neoplasms; Nitric Oxide; Picrates; Plant Extracts; Tetrazolium Salts; Thiazoles	2012
Synthesis and antitumor activity of α-aminophosphonates containing thiazole[5,4-b]pyridine moiety. Organic & biomolecular chemistry, 2012, Sep-21, Volume: 10, Issue:35 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Neoplasms; Organophosphonates; Pyridines; Thiazoles	2012
Lab reports and cat scans: can veterinary oncology guide our way to new treatments for human cancers? Future medicinal chemistry, 2012, Volume: 4, Issue:11 Topics: Animals; Antineoplastic Agents; Benzamides; Breast Neoplasms; Cats; Disease Models, Animal; Dogs; Female; Humans; Imatinib Mesylate; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mast-Cell Sarcoma; Neoplasms; Piperazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Thiazoles; Transcriptome	2012
Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents. Bioorganic & medicinal chemistry letters, 2012, Sep-01, Volume: 22, Issue:17 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Isoxazoles; Neoplasms; Structure-Activity Relationship; Thiazoles; Triazoles	2012
Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition. Proceedings of the National Academy of Sciences of the United States of America, 2012, Aug-21, Volume: 109, Issue:34 Topics: Amyloid; Benzothiazoles; Humans; Kinetics; Ligands; Light; Microscopy, Electron; Mutation; Neoplasms; Protein Binding; Protein Conformation; Protein Denaturation; Protein Folding; Scattering, Radiation; Thiazoles; Tumor Suppressor Protein p53	2012
Dissecting the phenotypes of Plk1 inhibition in cancer cells using novel kinase inhibitory chemical CBB2001. Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:10 Topics: Amides; Animals; Aurora Kinase A; Aurora Kinases; Benzimidazoles; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Female; Geminin; Glycine; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Nitriles; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Sulfones; Thiazoles	2012
Identification of novel piperazinylquinoxaline derivatives as potent phosphoinositide 3-kinase (PI3K) inhibitors. PloS one, 2012, Volume: 7, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Enzyme Inhibitors; Flow Cytometry; HL-60 Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Tetrazolium Salts; Thiazoles	2012
Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs. Bioorganic & medicinal chemistry letters, 2012, Oct-15, Volume: 22, Issue:20 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Neoplasms; Structure-Activity Relationship; Thiazoles	2012
Discovery of novel dihydroimidazothiazole derivatives as p53-MDM2 protein-protein interaction inhibitors: synthesis, biological evaluation and structure-activity relationships. Bioorganic & medicinal chemistry letters, 2012, Oct-15, Volume: 22, Issue:20 Topics: Drug Design; Humans; Imidazoles; Neoplasms; Protein Interaction Maps; Proto-Oncogene Proteins c-mdm2; Thiazoles; Tumor Suppressor Protein p53	2012
Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity. Toxicology and applied pharmacology, 2012, Nov-15, Volume: 265, Issue:1 Topics: Amino Acid Transport System ASC; Amino Acid Transport Systems; Animals; Antineoplastic Agents; Binding Sites; Computer Simulation; Cysteine; Dose-Response Relationship, Drug; Glutamine; Kinetics; Minor Histocompatibility Antigens; Neoplasms; Proteolipids; Rats; Structure-Activity Relationship; Thiazoles	2012
Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen. PloS one, 2012, Volume: 7, Issue:10 Topics: Algorithms; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cluster Analysis; Colchicine; Computational Biology; Cyclin-Dependent Kinases; Dasatinib; Databases, Genetic; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Neoplasms; Oligonucleotide Array Sequence Analysis; Paclitaxel; Pimozide; Purines; Pyrimidines; Terfenadine; Thiazoles; Tubulin Modulators; Verapamil	2012
Cancer cell resistance to aurora kinase inhibitors: identification of novel targets for cancer therapy. Journal of proteome research, 2013, Jan-04, Volume: 12, Issue:1 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Antineoplastic Agents; Apoptosis; Aurora Kinases; Benzamides; Drug Resistance, Neoplasm; GTP-Binding Proteins; HCT116 Cells; Humans; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Quinazolines; Thiazoles; Tumor Suppressor Protein p53	2013
Synthesis and characterization of a small analogue of the anticancer natural product leinamycin. Bioorganic & medicinal chemistry, 2013, Jan-01, Volume: 21, Issue:1 Topics: Alkylation; Antineoplastic Agents; Biological Products; DNA; DNA Cleavage; Humans; Lactams; Macrolides; Neoplasms; Oxidation-Reduction; Streptomyces; Sulfhydryl Compounds; Thiazoles; Thiones	2013
Integrity of p53 associated pathways determines induction of apoptosis of tumor cells resistant to Aurora-A kinase inhibitors. PloS one, 2013, Volume: 8, Issue:1 Topics: Animals; Apoptosis; Aurora Kinase A; Aurora Kinases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Female; HCT116 Cells; Humans; Mice; Neoplasms; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2013
Rhodacyanine dye MKT-077 inhibits in vitro telomerase assay but has no detectable effects on telomerase activity in vivo. Cancer research, 2002, Aug-01, Volume: 62, Issue:15 Topics: Cell Division; Cell Line, Transformed; Coloring Agents; Enzyme Inhibitors; HSP70 Heat-Shock Proteins; Humans; Mitochondrial Proteins; Neoplasms; Pyridines; ras Proteins; Telomerase; Telomere; Thiazoles; Tumor Suppressor Protein p53	2002
Augmentation of macrophage antitumor activities and nitric oxide production by oregonin. Archives of pharmacal research, 2002, Volume: 25, Issue:4 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Separation; Cytotoxicity Tests, Immunologic; Diarylheptanoids; In Vitro Techniques; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Neoplasms; Neoplasms, Experimental; Nitric Oxide; Stimulation, Chemical; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2002
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. Molecular cancer therapeutics, 2002, Volume: 1, Issue:14 Topics: Actins; Apoptosis; CCAAT-Enhancer-Binding Proteins; Coloring Agents; Cyclophilins; DNA; Drug Design; GADD45 Proteins; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Kinetics; Male; Models, Chemical; Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Prostatic Neoplasms; Proteins; RNA, Messenger; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Time Factors; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured; Up-Regulation	2002
Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer. Proceedings of the National Academy of Sciences of the United States of America, 2003, Mar-04, Volume: 100, Issue:5 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Division; Cell Line; Cell Transformation, Neoplastic; Coloring Agents; DNA-Binding Proteins; Dose-Response Relationship, Drug; E2F Transcription Factors; E2F1 Transcription Factor; Flow Cytometry; Humans; Models, Biological; Naphthoquinones; Neoplasms; Retinoblastoma Protein; S Phase; Tetrazolium Salts; Thiazoles; Transcription Factors; Tumor Cells, Cultured	2003
Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant. Journal of molecular biology, 2003, Mar-28, Volume: 327, Issue:3 Topics: Amyloid; Benzothiazoles; Circular Dichroism; Coloring Agents; Congo Red; Dose-Response Relationship, Drug; Guanidine; Hot Temperature; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Microscopy, Electron; Mutation; Neoplasms; Protein Binding; Protein Conformation; Protein Denaturation; Protein Folding; Protein Structure, Secondary; Protein Structure, Tertiary; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Temperature; Thiazoles; Time Factors; Tumor Suppressor Protein p53	2003
PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner. Oncogene, 2003, Jul-03, Volume: 22, Issue:27 Topics: 3T3 Cells; Adipocytes; Animals; Apoptosis; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Flow Cytometry; G1 Phase; G2 Phase; Gene Expression Regulation; Histone Deacetylases; In Situ Nick-End Labeling; Luciferases; Mice; Microscopy, Fluorescence; Mitosis; Neoplasms; Plasmids; Precipitin Tests; Receptors, Cytoplasmic and Nuclear; Retinoblastoma Protein; RNA, Small Interfering; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection	2003
Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. The Journal of pharmacology and experimental therapeutics, 2003, Volume: 307, Issue:1 Topics: Antioxidants; Bromodeoxyuridine; Catalase; Catechin; Epithelial Cells; Flavonoids; Humans; Neoplasms; Oxidative Stress; Phenols; Polymers; Reactive Oxygen Species; Superoxide Dismutase; Tea; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2003
Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. International journal of oncology, 2003, Volume: 23, Issue:4 Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Death; Cell Division; Cell Line, Tumor; Chromatography, High Pressure Liquid; Coloring Agents; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Diterpenes; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Humans; Neoplasms; Oncogene Proteins, Viral; Repressor Proteins; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Tumor Suppressor Protein p53	2003
Further experience with amiphenazole and morphine in intractable pain. British medical journal, 1956, Jan-21, Volume: 1, Issue:4959 Topics: Humans; Morphine; Neoplasms; Pain, Intractable; Thiazoles	1956
AMIPHENAZOLE and morphine. British medical journal, 1956, Jan-21, Volume: 1, Issue:4959 Topics: Humans; Morphine; Neoplasms; Thiazoles	1956
[The effects of methylthiouracil and aminothiazole in severe thyrotoxic strumas]. Srpski arhiv za celokupno lekarstvo, 1955, Volume: 83, Issue:9 Topics: Hyperthyroidism; Methylthiouracil; Neoplasms; Thiazoles; Thiouracil	1955
The treatment of intractable pain with large doses of morphine and amiphenazole (daptazole). Acta anaesthesiologica Scandinavica, 1958, Volume: 2, Issue:1 Topics: Humans; Morphine; Neoplasms; Pain, Intractable; Thiazoles	1958
Ineffectiveness of five compounds on spontaneous mammary tumors of mice. Cancer chemotherapy reports, 1963, Volume: 27 Topics: Animals; Chlorprothixene; Fluorouracil; Hydrocarbons; Mammary Neoplasms, Animal; Mice; Naphthoquinones; Neoplasms; Neoplasms, Experimental; Thiazoles	1963
[STUDY OF THE ANTITUMOR ACTIVITY OF SOME DERIVATIVES OF 2,3-DI(ISOTHIURONIUM)-PROPANOL AND 2-IMINO-5-(ISOTHIURONIUM)-METHYLTHIAZOLIDINE]. Voprosy onkologii, 1964, Volume: 10 Topics: 1-Propanol; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Isothiuronium; Neoplasms; Neoplasms, Experimental; Research; Sarcoma; Sarcoma, Experimental; Thiazoles; Toxicology	1964
FLUORINE-CONTAINING POTENTIAL ANTICANCER AGENTS. II. SYNTHESES OF SOME TRIFLUOROMETHYLPURINES AND TRIFLUOROMETHYLTHIAZOLOPYRIMIDINES. Journal of medicinal chemistry, 1964, Volume: 7 Topics: Antineoplastic Agents; Chemistry, Pharmaceutical; Fluorine; Mice; Neoplasms; Neoplasms, Experimental; Pharmacology; Purines; Pyrimidines; Research; Thiazoles	1964
[CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. 35. RELATIONSHIP OF ANTITUMOR EFFECT BETWEEN CHEMICAL STRUCTURE OF NITROFURAN DERIVATIVES]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1964, Volume: 84 Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Chemistry, Pharmaceutical; Furans; Mice; Neoplasms; Nitrofurans; Pharmacology; Quinolines; Research; Thiazoles; Triazines	1964
AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER. Cancer chemotherapy reports, 1964, Volume: 43 Topics: Alkylating Agents; Amides; Antineoplastic Agents; Azirines; Biomedical Research; Breast Neoplasms; Drug Therapy; Heterocyclic Compounds; Humans; Neoplasms; Phosphinic Acids; Thiazoles; Toxicology	1964
Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. International journal of cancer, 2004, Volume: 109, Issue:1 Topics: Animals; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weight; Camptothecin; Cell Line, Tumor; Cisplatin; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Heme Oxygenase (Decyclizing); Humans; Hydrogen Peroxide; Male; Metalloporphyrins; Mice; Mitomycin; Neoplasms; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Polyethylene Glycols; Proline; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles	2004
[Effect of aminothiazole on epithelial neoplasms from 20-methylcholanthrene in albino mouse]. Archivio italiano di anatomia e istologia patologica, 1951, Volume: 24, Issue:1 Topics: Animals; Methylcholanthrene; Mice; Neoplasms; Neoplasms, Glandular and Epithelial; Skin; Thiazoles	1951
Retroviral delivery of TIMP-2 inhibits H-ras-induced migration and invasion in MCF10A human breast epithelial cells. Cancer letters, 2004, Apr-15, Volume: 207, Issue:1 Topics: Cell Line; Cell Line, Transformed; Cell Line, Tumor; Cell Movement; Cells, Cultured; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Transfer Techniques; Genetic Therapy; Humans; Immunoblotting; Models, Genetic; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phenotype; ras Proteins; Retroviridae; Tetrazolium Salts; Thiazoles; Time Factors; Tissue Inhibitor of Metalloproteinase-2; Wound Healing	2004
The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer. Molecular cancer therapeutics, 2004, Volume: 3, Issue:8 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Cisplatin; Coloring Agents; DNA; DNA Damage; DNA Repair; Down-Regulation; Drug Evaluation, Preclinical; Endonucleases; Etoposide; Exonucleases; Fluorouracil; HeLa Cells; Humans; Kinetics; Mice; Mitomycin; Neoplasms; Pentamidine; Plasmids; Recombination, Genetic; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Time Factors	2004
Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells. Drug metabolism and disposition: the biological fate of chemicals, 2004, Volume: 32, Issue:12 Topics: Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Indicators and Reagents; Microsomes; Neoplasms; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Rhodamines; RNA, Messenger; Tetrazolium Salts; Thiazoles	2004
A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2. The Journal of biological chemistry, 2005, Feb-11, Volume: 280, Issue:6 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens; Antineoplastic Agents; Binding, Competitive; Blotting, Western; Cell Line, Tumor; Coloring Agents; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epitopes; Escherichia coli; Genetic Vectors; Glutathione Transferase; Humans; Immunoglobulin G; Mice; Mice, Inbred BALB C; Models, Molecular; Mutation; Neoplasms; NIH 3T3 Cells; Peptide Library; Peptides; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Receptor, ErbB-2; Recombinant Fusion Proteins; Recombinant Proteins; Spleen; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Trastuzumab	2005
Highly efficient redirected anti-tumor activity of human lymphocytes transduced with a completely human chimeric immune receptor. The journal of gene medicine, 2005, Volume: 7, Issue:2 Topics: Antibodies, Monoclonal; Blotting, Western; CD3 Complex; Cell Line, Tumor; Cell Proliferation; Chromium Radioisotopes; DNA Primers; Flow Cytometry; Fluorescent Antibody Technique; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Immunoglobulin Variable Region; Immunotherapy; Leukemia Virus, Gibbon Ape; Lymphocytes; Neoplasms; Receptor, ErbB-2; Tetrazolium Salts; Thiazoles; Transduction, Genetic	2005
A correlation between membrane cholesterol level, cell adhesion and tumourigenicity of polyoma virus transformed cells. Molecular and cellular biochemistry, 2004, Volume: 265, Issue:1-2 Topics: Actins; Animals; Cell Adhesion; Cell Line; Cell Line, Transformed; Cell Membrane; Cell Proliferation; Cell Transformation, Viral; CHO Cells; Cholesterol; Coloring Agents; Cricetinae; Female; Fibroblasts; Fibronectins; Integrin alpha5beta1; Integrins; Male; Mice; Mice, Nude; Neoplasms; Polyomavirus; Rats; Spectrometry, Fluorescence; Talin; Tetrazolium Salts; Thiazoles; Time Factors	2004
Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity. Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9 Topics: Antimetabolites, Antineoplastic; Brain; Brain Neoplasms; Cell Line, Tumor; Coloring Agents; Cytarabine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Leukemia; Neoplasms; Retinoblastoma; Tetrazolium Salts; Thiazoles	2004
p73 beta-expressing recombinant adenovirus: a potential anticancer agent. Cancer gene therapy, 2005, Volume: 12, Issue:4 Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Separation; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Gene Transfer Techniques; Genes, Tumor Suppressor; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Neoplasms; Nuclear Proteins; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2005
YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:1 Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Blotting, Western; Cell Movement; Cell Proliferation; Endothelial Cells; Endothelium, Vascular; Enzyme Activators; Extracellular Signal-Regulated MAP Kinases; Fibroblast Growth Factor 2; Guanylate Cyclase; Humans; Indazoles; Longevity; Microtubules; Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Protein Kinase C; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymidine; Vascular Endothelial Growth Factor A	2005
IB1/JIP-1 controls JNK activation and increased during prostatic LNCaP cells neuroendocrine differentiation. Cellular signalling, 2005, Volume: 17, Issue:8 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Benzimidazoles; Blotting, Northern; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Densitometry; Disease Progression; Enzyme Activation; Epithelial Cells; Fenretinide; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; Luciferases; Male; MAP Kinase Kinase 4; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Neurons; Neurosecretory Systems; Phenotype; Plasmids; Prostate; Prostatic Neoplasms; Rats; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Synaptophysin; Tetrazolium Salts; Thiazoles; Tissue Distribution; Transcription Factors; Transcription, Genetic; Up-Regulation	2005
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proceedings of the National Academy of Sciences of the United States of America, 2005, May-31, Volume: 102, Issue:22 Topics: Animals; Carbocyanines; Fluorometry; Integrins; Ligands; Mice; Mice, Nude; Microscopy, Fluorescence; Molecular Probe Techniques; Neoplasms; Oligopeptides; Peptides, Cyclic; Snake Venoms; Spectrophotometry; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2005
Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Life sciences, 2005, Sep-16, Volume: 77, Issue:18 Topics: Amlodipine; Analysis of Variance; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Therapy; Flow Cytometry; Fluorescence; Humans; K562 Cells; Neoplasms; Rhodamine 123; Tetrazolium Salts; Thiazoles; Time Factors; Verapamil	2005
Sensitivity of human cord blood cells to tetrachloroethylene: cellular and molecular endpoints. Archives of toxicology, 2005, Volume: 79, Issue:9 Topics: Apoptosis; Blotting, Western; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Erythroid Precursor Cells; Fetal Blood; Flow Cytometry; Genes, Tumor Suppressor; Humans; In Vitro Techniques; Neoplasms; Oligonucleotide Array Sequence Analysis; Oncogenes; Reverse Transcriptase Polymerase Chain Reaction; RNA; Solvents; Tetrachloroethylene; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay; Up-Regulation	2005
Schisandrin B--a novel inhibitor of P-glycoprotein. Biochemical and biophysical research communications, 2005, Sep-23, Volume: 335, Issue:2 Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Models, Chemical; Neoplasms; Polycyclic Compounds; Protein Binding; Tetrazolium Salts; Thiazoles; Time Factors	2005
RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. The Journal of biological chemistry, 2005, Oct-28, Volume: 280, Issue:43 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Collagen; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix; Gene Silencing; Humans; Immunoblotting; Laminin; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Plasmids; Prostatic Neoplasms; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Transfection; Urokinase-Type Plasminogen Activator	2005
The inhibitory effect and possible mechanisms of D-allose on cancer cell proliferation. International journal of oncology, 2005, Volume: 27, Issue:4 Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA; Fructose; Gene Expression Regulation, Neoplastic; Glucose; HeLa Cells; Hexoses; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Models, Chemical; Monosaccharides; Neoplasms; Reactive Oxygen Species; Sugar Alcohols; Tetrazolium Salts; Thiazoles; Time Factors	2005
A clinoptilolite effect on cell media and the consequent effects on tumor cells in vitro. Frontiers in bioscience : a journal and virtual library, 2006, May-01, Volume: 11 Topics: Animals; Apoptosis; Blotting, Western; Calcium; Cell Line, Tumor; Cell Survival; Chromatography, Ion Exchange; Culture Media; DNA; ErbB Receptors; Humans; Immunoprecipitation; In Vitro Techniques; Ions; MAP Kinase Kinase 4; Mice; Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymidine; Time Factors; Zeolites	2006
Rho/ROCK pathway as a target of tumor therapy. Journal of neuroscience research, 2006, Feb-01, Volume: 83, Issue:2 Topics: Amides; Animals; Antineoplastic Agents; Apoptosis; Blotting, Southern; Blotting, Western; Caspases; Cell Survival; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Lovastatin; Male; Mevalonic Acid; Mice; Neoplasms; Neoplasms, Experimental; Polyisoprenyl Phosphates; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured	2006
The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer letters, 2006, Oct-28, Volume: 242, Issue:2 Topics: Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Flavonoids; Humans; Models, Chemical; Mutation; Neoplasms; Plant Extracts; Tetrazolium Salts; Thiazoles	2006
New antitumour active platinum compounds containing carboxylate ligands in trans geometry: synthesis, crystal structure and biological activity. Dalton transactions (Cambridge, England : 2003), 2006, Feb-28, Issue:8 Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Inhibitory Concentration 50; Ligands; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Neoplasms; Platinum Compounds; Tetrazolium Salts; Thiazoles	2006
YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Mar-01, Volume: 12, Issue:5 Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gefitinib; Humans; Male; Mice; Mice, Inbred ICR; Mice, Nude; Molecular Structure; Neoplasms; Neovascularization, Pathologic; Paclitaxel; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Quinazolines; Thiazoles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2006
Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model. The American journal of pathology, 2006, Volume: 168, Issue:5 Topics: Animals; Cytosol; Disease Models, Animal; Hemocytes; HSP70 Heat-Shock Proteins; Immunohistochemistry; Immunoprecipitation; Leukemia; Molecular Sequence Data; Mya; Neoplasms; Pyridines; Subcellular Fractions; Thiazoles; Tumor Suppressor Protein p53	2006
Impact of genetic diagnostics on drug development strategy. Nature reviews. Drug discovery, 2006, Volume: 5, Issue:6 Topics: Antineoplastic Agents; Dasatinib; Drug Design; Drug Resistance, Neoplasm; Gefitinib; Genetic Testing; Humans; Neoplasms; Pharmacogenetics; Pyrimidines; Quinazolines; Thiazoles	2006
Inhibitors of epidermal growth factor receptor tyrosine kinase: optimisation of potency and in vivo pharmacokinetics. Bioorganic & medicinal chemistry letters, 2006, Sep-15, Volume: 16, Issue:18 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; ErbB Receptors; Fluorine; Gefitinib; Humans; Inhibitory Concentration 50; Mice; Molecular Structure; Neoplasms; Protein Kinase Inhibitors; Quinazolines; Rats; Structure-Activity Relationship; Thiazoles; Xenograft Model Antitumor Assays	2006
In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. Journal of controlled release : official journal of the Controlled Release Society, 2006, Aug-28, Volume: 114, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Nucleus; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, MDR; Humans; Liposomes; Mice; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms; Oligonucleotides, Antisense; Polyethylene Glycols; RNA, Messenger; Tetrazolium Salts; Thiazoles	2006
Pharmacy benefit spending on oral chemotherapy drugs. Journal of managed care pharmacy : JMCP, 2006, Volume: 12, Issue:7 Topics: Administration, Oral; Ambulatory Care; Antineoplastic Agents; Benzamides; Benzenesulfonates; Capecitabine; Dasatinib; Deoxycytidine; Drug Costs; Employer Health Costs; Erlotinib Hydrochloride; Fluorouracil; Gefitinib; Health Benefit Plans, Employee; Humans; Imatinib Mesylate; Indoles; Insurance, Pharmaceutical Services; Lenalidomide; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Prescription Fees; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib; Thalidomide; Thiazoles; United States	2006
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells. Cancer research, 2006, Dec-01, Volume: 66, Issue:23 Topics: Aniline Compounds; Animals; Benzamides; Cell Line; Cell Line, Tumor; Cell Proliferation; Dasatinib; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Genotype; Humans; Imatinib Mesylate; K562 Cells; Mice; Mice, Nude; Models, Molecular; Mutation; Neoplasms; Nitriles; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Quinolines; src-Family Kinases; Survival Analysis; Thiazoles; U937 Cells; Xenograft Model Antitumor Assays	2006
Synthesis and antitumor activity of guanylhydrazones from 6-(2,4-dichloro-5-nitrophenyl)imidazo[2,1-b]thiazoles and 6-pyridylimidazo[2,1-b]thiazoles(1). Journal of medicinal chemistry, 2006, Dec-28, Volume: 49, Issue:26 Topics: Adenosylmethionine Decarboxylase; Antineoplastic Agents; Cell Cycle; Cell Death; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Hydrazones; Membrane Potential, Mitochondrial; Molecular Structure; Neoplasms; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured	2006
Paradoxical proliferative potential of iron (II) sulphate on cancer cells after the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. International journal of molecular medicine, 2007, Volume: 19, Issue:6 Topics: Breast Neoplasms; Carcinoma; Cell Proliferation; Colony-Forming Units Assay; Humans; Iron Compounds; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Sulfates; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2007
Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. Journal of the National Cancer Institute, 2007, Jul-04, Volume: 99, Issue:13 Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Mice; Mice, Inbred C57BL; Micelles; Nanoparticles; Neoplasms; Phosphatidylethanolamines; Phospholipids; Polyethylene Glycols; Tetrazolium Salts; Thiazoles	2007
American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 4. IDrugs : the investigational drugs journal, 2007, Volume: 10, Issue:8 Topics: Anthracyclines; Antineoplastic Agents; Biomarkers, Tumor; Biomedical Research; CA-125 Antigen; Clinical Trials as Topic; Dasatinib; Female; Humans; Indazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; Neoplasms; Ovarian Neoplasms; Pyrimidines; Snake Venoms; Sulfonamides; Thiazoles; Treatment Outcome	2007
Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. International journal of radiation biology, 2007, Volume: 83, Issue:10 Topics: Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Radiation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioma; Humans; Meloxicam; Neoplasms; Nitrobenzenes; Pyrazoles; Radiation-Protective Agents; Sulfonamides; Thiazines; Thiazoles	2007
Inhibitory effects of nitric oxide on invasion of human cancer cells. Cancer letters, 2007, Nov-18, Volume: 257, Issue:2 Topics: Antimycin A; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Electron Transport Complex III; Humans; Hypoxia-Inducible Factor 1; Immunoblotting; Iron-Sulfur Proteins; Methacrylates; Mitochondria; Neoplasm Invasiveness; Neoplasms; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Oligomycins; RNA Interference; RNA, Small Interfering; Thiazoles; Transfection; Uncoupling Agents	2007
Active nanodiamond hydrogels for chemotherapeutic delivery. Nano letters, 2007, Volume: 7, Issue:11 Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Cell Line, Tumor; Colonic Neoplasms; Diamond; Doxorubicin; Drug Delivery Systems; Humans; Macrophages; Mice; Nanoparticles; Nanotechnology; Neoplasms; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Thiazoles	2007
Shikonin analogue (SA) 93/637 induces apoptosis by activation of caspase-3 in U937 cells. Frontiers in bioscience : a journal and virtual library, 2008, Jan-01, Volume: 13 Topics: Apoptosis; Caspase 3; Cell Survival; Cinnamates; DNA Fragmentation; Enzyme Activation; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Naphthoquinones; Neoplasms; Ribonucleases; Tetrazolium Salts; Thiazoles; Transcription, Genetic; U937 Cells	2008
The chemopreventive effects of Saussurea salicifolia through induction of apoptosis and phase II detoxification enzyme. Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromatin; DNA, Neoplasm; Enzyme Induction; Ethanol; Flow Cytometry; Furans; Humans; Lactones; Lignans; Metabolic Detoxication, Phase II; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Plant Extracts; Saussurea; Sesquiterpenes; Solvents; Tetrazolium Salts; Thiazoles	2007
Comparative thiamine saturations in women with uterine cancer and in normal women. Cancer, 1949, Volume: 2, Issue:1 Topics: Female; Humans; Neoplasms; Thiamine; Thiazoles; Uterine Neoplasms	1949
Distinct H2O2 concentration promotes proliferation of tumour cells after transient oxygen/glucose deprivation. Free radical research, 2008, Volume: 42, Issue:3 Topics: Animals; Antioxidants; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glucose; Hydrogen Peroxide; Models, Biological; Neoplasms; Oxygen; Rats; Reperfusion Injury; Tetrazolium Salts; Thiazoles; Time Factors	2008
Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway. Proceedings of the National Academy of Sciences of the United States of America, 2008, Apr-29, Volume: 105, Issue:17 Topics: Animals; Antineoplastic Agents; Catechols; Cell Line, Tumor; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Mice; Mutant Proteins; Neoplasm Proteins; Neoplasms; Nuclear Proteins; RNA, Messenger; Small Molecule Libraries; Thiazoles; Transcription, Genetic; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2008
Testing the hypothesis that amphiphilic antineoplastic lipid analogues act through reduction of membrane curvature elastic stress. Journal of the Royal Society, Interface, 2008, Nov-06, Volume: 5, Issue:28 Topics: Antineoplastic Agents; Cell Membrane; Choline-Phosphate Cytidylyltransferase; Elasticity; HL-60 Cells; Humans; Micelles; Molecular Structure; Neoplasms; Phospholipid Ethers; Stress, Mechanical; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles	2008
Treatment of cancer by an inducer of reverse transformation. Lancet (London, England), 1980, Jan-12, Volume: 1, Issue:8159 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Neoplasms; Thiazoles; Thiazolidines	1980
Thioproline. Lancet (London, England), 1980, Mar-15, Volume: 1, Issue:8168 Pt 1 Topics: Administration, Oral; Child; Humans; Injections, Intravenous; Neoplasms; Thiazoles; Thiazolidines	1980
Thioproline and reversal of cancer. Lancet (London, England), 1983, May-14, Volume: 1, Issue:8333 Topics: Antineoplastic Agents; Humans; Neoplasms; Thiazoles; Thiazolidines	1983
Pilot study on the treatment with thioproline of 24 small animals with tumors. American journal of veterinary research, 1984, Volume: 45, Issue:10 Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Male; Neoplasms; Pilot Projects; Thiazoles; Thiazolidines	1984
[Transrecters. A new group of inducers of reverse transformation with possible use in the treatment of human cancer]. Revista espanola de oncologia, 1982, Volume: 29, Issue:4 Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; HeLa Cells; Humans; Neoplasms; Thiazoles; Thiazolidines	1982
Determination of thioproline in plasma using high performance liquid chromatography. Cancer letters, 1981, Volume: 12, Issue:1-2 Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Neoplasms; Thiazoles; Thiazolidines	1981
Mortality experience of employees exposed to 2-mercaptobenzothiazole at a chemical plant in Nitro, West Virginia. British journal of industrial medicine, 1993, Volume: 50, Issue:10 Topics: Adolescent; Adult; Aged; Antimetabolites; Benzothiazoles; Chemical Industry; Cohort Studies; Humans; Male; Middle Aged; Neoplasms; Occupational Diseases; Occupational Exposure; Risk Factors; Thiazoles; West Virginia	1993
Mortality study of workers employed at a plant manufacturing chemicals for the rubber industry: 1955-86. British journal of industrial medicine, 1993, Volume: 50, Issue:11 Topics: Benzothiazoles; Chemical Industry; Female; Follow-Up Studies; Humans; Male; Neoplasms; Occupational Diseases; Occupational Exposure; Rubber; Sex Factors; Thiazoles; Wales	1993
Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro. British journal of cancer, 1993, Volume: 67, Issue:6 Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Humans; Kinetics; Lung Neoplasms; Morpholines; Neoplasms; Receptors, Estrogen; Retinoids; Tetrazolium Salts; Thiazoles; Tretinoin; Tumor Cells, Cultured	1993
Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC. Surgery today, 1993, Volume: 23, Issue:3 Topics: Aged; Animals; Blood Pressure; Disseminated Intravascular Coagulation; Female; Fibrinolysis; Guanidines; Humans; Male; Middle Aged; Neoplasms; Platelet Activating Factor; Platelet Count; Postoperative Complications; Rabbits; Serine Proteinase Inhibitors; Shock, Septic; Thiazoles; Thiazolidines	1993
MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. Cancer research, 1996, Feb-01, Volume: 56, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Chlorocebus aethiops; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Ethanol; Female; Flow Cytometry; Humans; Kidney; Male; Mice; Mice, Nude; Microscopy, Confocal; Microscopy, Video; Mitochondria; Neoplasm Transplantation; Neoplasms; Pyridines; Solubility; Thiazoles; Tumor Cells, Cultured	1996
Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. Cancer research, 1996, Feb-01, Volume: 56, Issue:3 Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chlorocebus aethiops; DNA, Mitochondrial; Electron Transport; Epithelium; Humans; Male; Microscopy, Electron; Mitochondria, Liver; Neoplasms; Oxygen Consumption; Pyridines; Rats; Rats, Sprague-Dawley; Thiazoles; Tumor Cells, Cultured	1996
The in vitro effect of Pidotimod on some immune functions in cancer patients. Immunopharmacology and immunotoxicology, 1997, Volume: 19, Issue:1 Topics: Adjuvants, Immunologic; Female; Humans; Immunity, Cellular; Immunologic Factors; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines	1997
Quantification of tumour cell-endothelial cell attachment by 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine (DiI). Cancer letters, 1997, Jan-30, Volume: 112, Issue:2 Topics: Bisbenzimidazole; Carbocyanines; Cell Adhesion; Cell Communication; Endothelium, Vascular; Fluorescent Dyes; Humans; Neoplasms; Sensitivity and Specificity; Tetrazolium Salts; Thiazoles	1997
Carcinogenicity studies on ebrotidine. Arzneimittel-Forschung, 1997, Volume: 47, Issue:4A Topics: Animals; Benzenesulfonates; Body Weight; Carcinogenicity Tests; Female; Histamine H2 Antagonists; Male; Mice; Neoplasms; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Survival Rate; Thiazoles	1997
Activity and distribution of the cysteine prodrug activating enzyme, 5-oxo-L-prolinase, in human normal and tumor tissues. Cancer letters, 1997, Jul-15, Volume: 117, Issue:1 Topics: Cysteine; Humans; Neoplasms; Prodrugs; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines	1997
Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: a potential new target for biochemical modulation of glutathione. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:1 Topics: Animals; Female; Glutathione; Humans; Immunohistochemistry; Neoplasms; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred F344; Thiazoles; Thiazolidines	1998
Modulating activity of indomethacin to vincristine cytotoxicity in various human carcinoma cells. The Tohoku journal of experimental medicine, 1998, Volume: 186, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Survival; Coloring Agents; Female; Fibroblasts; Humans; Indomethacin; Lung Neoplasms; Male; Middle Aged; Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine	1998
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science (New York, N.Y.), 1999, Sep-10, Volume: 285, Issue:5434 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Division; Cell Line; Cell Nucleus; Cytoplasm; DNA; DNA Damage; G2 Phase; Gamma Rays; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms; Radiation Tolerance; Thiazoles; Time Factors; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays	1999
Cancer research. A new way to combat therapy side effects. Science (New York, N.Y.), 1999, Sep-10, Volume: 285, Issue:5434 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Division; Cells, Cultured; Drug Evaluation, Preclinical; Gamma Rays; Humans; Mice; Neoplasms; Radiation Dosage; Radiation Tolerance; Thiazoles; Toluene; Tumor Suppressor Protein p53	1999
Indanocine, a microtubule-binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells. Journal of the National Cancer Institute, 2000, Feb-02, Volume: 92, Issue:3 Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Coloring Agents; DNA Fragmentation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Precursors; Flow Cytometry; Fluorescent Antibody Technique; Fluorometry; Humans; Indans; Microtubules; Neoplasms; Polymers; Protein Binding; Tetrazolium Salts; Thiazoles; Tubulin; Tumor Cells, Cultured	2000
A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-beta-naphthylamine and o-toluidine. Occupational and environmental medicine, 2000, Volume: 57, Issue:2 Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Aged, 80 and over; Aniline Compounds; Benzothiazoles; Cohort Studies; Humans; Male; Middle Aged; Neoplasms; Occupational Diseases; Occupational Exposure; Rubber; Thiazoles; Toluidines; Wales	2000
Interferon-gamma-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis. Blood, 2000, Apr-01, Volume: 95, Issue:7 Topics: Adult; Azepines; Calcium; Cell Membrane; Cytotoxicity, Immunologic; Gene Expression; Humans; Interferon-gamma; Killer Cells, Natural; Membrane Glycoproteins; Neoplasms; Perforin; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pore Forming Cytotoxic Proteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Transfection; Triazoles; Tumor Cells, Cultured	2000
The clinical benefit of the histoculture drug response assay. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27 Suppl 2 Topics: Antineoplastic Agents; Colorectal Neoplasms; Coloring Agents; Drug Screening Assays, Antitumor; Humans; Neoplasms; Stomach Neoplasms; Survival Analysis; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2000
Functional assessment in vitro of human-complement-dependent antibody-induced cytotoxicity of neoplastic cells. Cancer immunology, immunotherapy : CII, 2000, Volume: 49, Issue:4-5 Topics: Animals; Antibodies, Monoclonal; Cell Death; Cell Division; Chemistry, Clinical; Complement C3c; Complement C4; Complement System Proteins; Dose-Response Relationship, Immunologic; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; G(M1) Ganglioside; Humans; Immunoglobulin G; Mice; Neoplasms; Rats; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured	2000
Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer research, 2000, Dec-15, Volume: 60, Issue:24 Topics: alpha Catenin; Animals; beta Catenin; Cadherins; Cell Adhesion; Cell Communication; Cell Division; Cell Survival; Coloring Agents; Contact Inhibition; Cytoplasm; Cytoskeletal Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Genes, Reporter; Immunoblotting; Male; Mice; Mutation; Neoplasms; Precipitin Tests; Prostatic Neoplasms; Protein Structure, Tertiary; Tetrazolium Salts; Thiazoles; Time Factors; Trans-Activators; Transcription, Genetic; Transfection	2000
An evaluation of the colorimetric assays based on enzymatic reactions used in the measurement of human natural cytotoxicity. Journal of immunological methods, 2001, May-01, Volume: 251, Issue:1-2 Topics: Chromium Radioisotopes; Colorimetry; Coloring Agents; Cytotoxicity Tests, Immunologic; Glycoside Hydrolases; Humans; In Vitro Techniques; Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2001
[Reversion of cancer and mitochondrial filamentation]. Anales de la Real Academia Nacional de Medicina, 2000, Volume: 117, Issue:4 Topics: Animals; Antineoplastic Agents; Doxorubicin; Drug Screening Assays, Antitumor; Mitochondria; Neoplasms; Rotenone; Thiazoles; Thiazolidines; Uncoupling Agents	2000
How can anti-diabetics suppress tumours? Trends in pharmacological sciences, 2001, Volume: 22, Issue:8 Topics: Humans; Hypoglycemic Agents; Neoplasms; Phosphoric Monoester Hydrolases; PTEN Phosphohydrolase; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Suppressor Proteins	2001
[Studies on inhibiting activities of five antitumour drugs to human cancer cell in vitro with MTT assay]. Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2001, Volume: 24, Issue:6 Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2001
Clinical trials referral resource. Current clinical trials of epothilone B analog (BMS-247550). Oncology (Williston Park, N.Y.), 2001, Volume: 15, Issue:9 Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Evaluation; Epothilones; Epoxy Compounds; Female; Humans; Male; Mice; Neoplasms; Thiazoles	2001
PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. The Journal of biological chemistry, 2002, Feb-15, Volume: 277, Issue:7 Topics: Blotting, Western; Cell Cycle; Cell Line; Cell Nucleus; Cloning, Molecular; Coloring Agents; Cytoplasm; DNA Damage; Dose-Response Relationship, Drug; Down-Regulation; Etoposide; Genes, Reporter; Glioblastoma; Humans; Microscopy, Confocal; Mutation; Neoplasms; Nuclear Proteins; Phosphoric Monoester Hydrolases; Precipitin Tests; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; PTEN Phosphohydrolase; Retroviridae; Signal Transduction; Tetrazolium Salts; Thiazoles; Transcription, Genetic; Transduction, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2002
Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452. Journal of natural products, 2002, Volume: 65, Issue:1 Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cyanobacteria; Depsipeptides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; Hawaii; Humans; Inhibitory Concentration 50; KB Cells; Leukemia L1210; Mass Spectrometry; Mice; Microscopy, Fluorescence; Microtubules; Molecular Structure; Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Oligopeptides; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured	2002
L-2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastases. Melanoma research, 2002, Volume: 12, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Female; Glutathione; Interleukin-2; Liver; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Time Factors; Tumor Cells, Cultured	2002
In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles. British journal of cancer, 2002, Apr-22, Volume: 86, Issue:8 Topics: Amines; Amino Acids; Aniline Compounds; Benzothiazoles; Blotting, Western; Cell Division; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Neoplasms; Prodrugs; Thiazoles; Time Factors; Tumor Cells, Cultured	2002
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1 Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2002
[Relations between the macrophage electrophoretic mobility test and the rhodanide level in patients with malignant tumors, autoaggression diseases and after transplantation]. Acta biologica et medica Germanica, 1975, Volume: 34, Issue:9 Topics: Animals; Antibody Formation; Autoimmune Diseases; Guinea Pigs; Humans; Kidney Transplantation; Lymphocyte Activation; Macrophages; Neoplasms; Postoperative Complications; Rhodanine; Thiazoles; Transplantation, Homologous	1975
[Counter-statement]. Deutsche medizinische Wochenschrift (1946), 1977, Jul-15, Volume: 102, Issue:28 Topics: Amygdalin; Humans; Immunity; Neoplasms; Thiazoles	1977
Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cell Separation; Colorimetry; Coloring Agents; Drug Screening Assays, Antitumor; Female; Humans; Male; Middle Aged; Neoplasms; Succinate Dehydrogenase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	1991
Human multi-drug-resistant cancer cells exhibit a high degree of selectivity for stereoisomers of verapamil and quinidine. International journal of cancer, 1990, Jul-15, Volume: 46, Issue:1 Topics: Cell Line; Cell Survival; Coloring Agents; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; HeLa Cells; Humans; Neoplasms; Quinidine; Stereoisomerism; Tetrazolium Salts; Thiazoles; Verapamil; Vincristine	1990
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer research, 1986, Volume: 46, Issue:6 Topics: Antineoplastic Agents; Bleomycin; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cisplatin; Glutathione; Humans; Lung; Lung Neoplasms; Melphalan; Methionine Sulfoximine; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Zinostatin	1986
Synthesis and antineoplastic activity of 5-aryl-2,3-dihydropyrrolo[2,1-b]thiazole-6,7-dimethanol 6,7-bis(isopropylcarbamates). Journal of medicinal chemistry, 1988, Volume: 31, Issue:7 Topics: Carbamates; Cell Division; Cell Survival; Chemical Phenomena; Chemistry; Colonic Neoplasms; Humans; Leukemia, Myeloid; Neoplasms; Pyrroles; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured	1988
The role of the portal of entry in inhibition of tumorigenesis. Progress in experimental tumor research, 1971, Volume: 14 Topics: Animals; Azoles; Benzopyrenes; Biotransformation; Carcinogens; Diet; Dietary Fats; Environmental Pollution; Enzyme Induction; Flavonoids; Histocytochemistry; Hydrocarbons; Intestine, Small; Liver; Lung; Methylcholanthrene; Mice; Mice, Inbred Strains; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; Neoplasms; Phenobarbital; Phenothiazines; Placenta; Polycyclic Compounds; Protein Binding; Rats; Rats, Inbred Strains; Skin; Thiazoles	1971
Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. The New England journal of medicine, 1973, Aug-16, Volume: 289, Issue:7 Topics: Adult; Aged; Chlorine; Female; Humans; Hypersensitivity, Delayed; Imidazoles; Immunity, Cellular; Male; Middle Aged; Neoplasms; Nitrobenzenes; Skin; Skin Tests; Thiazoles; Tuberculin	1973
Levamisole and cell-mediated immunity. The New England journal of medicine, 1973, Aug-16, Volume: 289, Issue:7 Topics: Animals; Chlorine; Guinea Pigs; Humans; Hypersensitivity, Delayed; Imidazoles; Immunity, Cellular; Lymphocytes; Neoplasms; Nitrobenzenes; Skin; Skin Tests; Thiazoles; Tuberculin	1973
[Effect of leyk on leukopenia induced by radiotherapy]. Rinsho hoshasen. Clinical radiography, 1970, Volume: 15, Issue:11 Topics: Adult; Aged; Female; Humans; Leukocyte Count; Leukopenia; Male; Middle Aged; Neoplasms; Radiotherapy; Thiazoles	1970